SANDATA INC
S-3/A, 1997-04-25
COMPUTER PROCESSING & DATA PREPARATION
Previous: SIERRA HEALTH SERVICES INC, DEF 14A, 1997-04-25
Next: CONSOLIDATED CAPITAL PROPERTIES VI, SC 13D/A, 1997-04-25




   
     As filed with the Securities and Exchange Commission on April 25, 1997
                           Registration No. 333-22165
    

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


   
                                 AMENDMENT NO. 2
                                       TO
                                    FORM S-3
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933
    


                                  SANDATA, INC.
             (Exact Name of Registrant as Specified in Its Charter)

                                    Delaware
                 (State or Other Jurisdiction of Incorporation)
                                   11-2841799
                     (I.R.S. Employer Identification Number)

                              26 Harbor Park Drive
                         Port Washington, New York 11050
                                 (516) 484-9060
    (Address, Including Zip Code, and Telephone Number, Including Area Code,
                  of Registrant's Principal Executive Offices)

                                 Bert E. Brodsky
                                    President
                                  Sandata, Inc.
                              26 Harbor Park Drive
                         Port Washington, New York 11050
                                 (516) 484-9060
            (Name, Address, Including Zip Code, and Telephone Number,
                   Including Area Code, of Agent For Service)


                  Copies of all communications and notices to:

                           Steven J. Kuperschmid, Esq.
                       Certilman Balin Adler & Hyman, LLP
                                90 Merrick Avenue
                           East Meadow, New York 11554
                                 (516) 296-7000


            Approximate date of commencement of proposed sale to the
           public: As soon as practicable after the effective date of
                          this Registration Statement.


<PAGE>



                       (Cover continued on following page)
                  If any of the securities  being registered on this form are to
                  be offered on a delayed or continuous  basis  pursuant to Rule
                  415 of the  Securities  Act of 1933,  check the following box.
                  [x]

                  If this form is filed to register additional securities for an
                  offering  pursuant to Rule 462(b)  under the  Securities  Act,
                  please check the  following  box and list the  Securities  Act
                  registration   statement  number  of  the  earlier   effective
                  registration statement for the same offering. [ ]

                  If this form is a  post-effective  amendment filed pursuant to
                  Rule 462(c) under the Securities  Act, check the following box
                  and list the Securities Act  registration  statement number of
                  the  earlier  effective  registration  statement  for the same
                  offering. [ ]

                  If delivery of the prospectus is expected to be made pursuant 
                  to Rule 434, please check the following box. [ ]




<PAGE>



                         CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>



   
                                                                                                      Proposed
                                                                               Proposed Maximum        Maximum
                                                      Amount to be               Offering Price  Aggregate Offering       Amount of
Title of Each Class of Securities to be Registered   Registered (1)                Per Share (2)      Price (2)     Registration Fee
- ------------------------------------------------ -----------------------  --------------------- -------------------  ---------------
<S>                                                       <C>                     <C>               <C>                <C>         
Common Stock, $.001                                       1,988,140               $10.38            $20,636,893        $6,253.60(3)
Par Value, registered for the benefit
of Selling Stockholders
    

================================================ =======================  ===================== ===================== ==============
</TABLE>

   
(1)               This Registration Statement also covers such additional number
                  of shares of Common  Stock as may be issuable by reason of the
                  operation   of  the   antidilution   provisions   of   certain
                  outstanding warrants.
(2)               Estimated solely for the purpose of calculating the amount of 
                  the registration fee pursuant to Rule 457(c).
(3)               Paid with the previous filings.
    



     The registrant  hereby amends this  Registration  Statement on such date or
dates as may be necessary to delay its effective date until the registrant shall
file a further  amendment  which  specifically  states  that  this  Registration
Statement shall  thereafter  become effective in accordance with Section 8(a) of
the Securities  Act of 1933 or until this  Registration  Statement  shall become
effective  on such  date  as the  Securities  and  Exchange  Commission,  acting
pursuant to said Section 8(a), may determine.




<PAGE>



   
                              Subject to Completion
                   Preliminary Prospectus Dated April 25, 1997
    

                                   PROSPECTUS


                1,988,140 SHARES OF COMMON STOCK, $.001 PAR VALUE


                                  SANDATA, INC.

     This Prospectus  relates to 1,988,140 shares of Common Stock (the "Shares")
of  Sandata,  Inc.  (the  "Company"),  or  approximately  170% of the  Company's
currently   issued   and   outstanding   shares  of  Common   Stock.   See  Risk
Factors--Effect of Outstanding Exercisable Securities" and "Risk Factors--Shares
Eligible  for Future Sale May  Adversely  Affect the  Market".  This  Prospectus
covers: (i) the resale by certain individuals and entities of up to an aggregate
of 300,000  Shares  issued by the Company  pursuant to  Subscription  Agreements
dated as of December  23, 1996,  (ii) the resale by certain  persons of up to an
aggregate  of 100,000  Shares  issued by the Company  pursuant  to  Subscription
Agreements dated as of September 13, 1996, (iii) the resale by certain Directors
and executive officers of the Company of up to an aggregate of 1,238,140 Shares,
including, without limitation,  shares underlying options and warrants, and (iv)
the resale by certain  individuals and entities of up to an aggregate of 350,000
shares issuable upon the exercise of outstanding warrants.

     The  various  persons  and  entities  referred  to herein  are  hereinafter
referred to  individually  as a "Selling  Stockholder"  and  collectively as the
"Selling Stockholders".  The Company will receive no proceeds upon the resale of
the Shares by such persons and entities.  There are no  commitments  pursuant to
which the Company will receive any proceeds from the resale of the Shares by the
Selling Stockholders. See "Selling Stockholders."

     In October,  1996,  the Company  commenced a private  offering,  on a "best
efforts--all  or none"  basis,  to raise  $1,500,000  by issuing an aggregate of
300,000  shares of  Common  Stock and five year  warrants  for the  purchase  of
150,000 shares of Common Stock at an exercise price of $7.00 per share.  Neither
the  shares  of Common  Stock,  the  warrants  nor the  shares  of Common  Stock
underlying  the warrants were  registered  under the  Securities Act of 1933, as
amended  (the  "Securities  Act").  Contemporaneously  with  the  execution  and
delivery  by the  Company of the letter of intent  with  regard to such  private
offering,  certain  assignees of the placement agent acquired  100,000 shares of
the Company's Common Stock at a purchase price of $3.00 per share.

     In connection  with the closing of such private  offering,  an affiliate of
the  placement  agent  entered into a financial  consulting  agreement  with the
Company  pursuant to which,  among other  things,  such  affiliate  will receive
aggregate  annual  payment of $36,000 and certain  assignees  of such  affiliate
received  warrants to purchase an  aggregate  of 200,000  shares of Common Stock
exercisable as follows:  100,000 shares at $5.00 per share and 100,000 shares at
$7.00 per share,  such warrants to be exercisable  for one year (with respect to
the warrants  exercisable at $5.00 per share) and two years (with respect to the
warrants  exercisable at $7.00 per share).  The warrants  issued in such private
offering,  including  those issued to investors as well as the  assignees of the
placement  agent's  affiliate,  are  redeemable  by the  Company  under  certain
circumstances.



<PAGE>



   
     Except for the  Shares of Messrs.  Bert E.  Brodsky,  Hugh  Freund and Gary
Stoller,  the  Shares  proposed  to be sold  hereby  were  acquired  (and may be
acquired upon exercise of the above mentioned warrants) by Selling  Stockholders
pursuant  to the above  mentioned  private  offering.  Among  other  things,  in
connection  with such private  offering,  the Company agreed to register,  under
certain  circumstances,  on one or more  occasions,  the Shares acquired by such
Selling  Stockholders  (including,  without limitation,  the placement agent) in
such private  offering.  The filing of the registration  statement of which this
Prospectus forms a part represents the fulfillment of certain obligations of the
Company to such Selling Stockholders.
    

     To the Company' s knowledge,  the Selling  Stockholders,  directly  through
agents  designated  by them  from  time to time  or  through  broker-dealers  or
underwriters also to be designated, may sell the Shares from time to time, in or
through  privately  negotiated  transactions,  or in one or  more  transactions,
including block  transactions,  on the NASDAQ SmallCap  Market,  or on any other
market or stock  exchange  on which  the  Shares  may be  listed  in the  future
pursuant  to and in  accordance  with the  applicable  rules of such  market  or
exchange or  otherwise.  The selling price of the Shares may be at market prices
prevailing  at the time of sale,  at prices  related to such  prevailing  market
prices  or at  negotiated  prices.  See  "Selling  Stockholders"  and  "Plan  of
Distribution".

     The Company  has agreed to  indemnify  certain of the Selling  Stockholders
against certain civil  liabilities,  including  liabilities under the Securities
Act. See "Selling Stockholders" and "Plan of Distribution".

     The Selling  Stockholders and any agents,  broker-dealers,  or underwriters
that participate with the Selling Stockholders in the distribution of any of the
Shares may be deemed to be  "underwriters"  within the meaning of the Securities
Act, and any  commissions  received by them, and any profit on the resale of the
Shares  purchased  by them,  may be deemed  to be  underwriting  commissions  or
discounts under the Securities Act. The Company is not aware of any underwriting
arrangements   with  respect  to  the  resale  of  the  Shares  by  the  Selling
Stockholders. See "Selling Stockholders" and "Plan of Distribution".

     A PURCHASE OF THESE  SECURITIES  INVOLVES A HIGH DEGREE OF RISK.  SEE "RISK
FACTORS" (PAGE 5).


          THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE
      SECURITIES AND EXCHANGE COMMISSION NOR HAS THE COMMISSION PASSED UPON
                THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY
              REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

   
     The Company's  Common Stock is traded on the NASDAQ  SmallCap  Market under
the symbol  "SAND".  On April 21, 1997,  the closing bid price for the Company's
Common Stock, as reported on the NASDAQ SmallCap Market, was $9.00.
    



                                     , 1997




<PAGE>



NO  DEALER,  SALESMAN  OR ANY  OTHER  PERSON  HAS  BEEN  AUTHORIZED  TO GIVE ANY
INFORMATION OR TO MAKE ANY  REPRESENTATION NOT CONTAINED IN THIS PROSPECTUS AND,
IF GIVEN OR MADE, SUCH INFORMATION OR REPRESENTATION  MUST NOT BE RELIED UPON AS
HAVING BEEN AUTHORIZED BY THE COMPANY OR ANY OTHER PERSON.  THIS PROSPECTUS DOES
NOT CONSTITUTE AN OFFER TO SELL OR A  SOLICITATION  OF AN OFFER TO BUY TO ANYONE
IN ANY  JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION IS NOT AUTHORIZED OR IN
WHICH THE PERSON MAKING SUCH OFFER OR SOLICITATION IS NOT QUALIFIED TO DO SO, OR
TO ANYONE TO WHOM IT IS UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION. NEITHER THE
DELIVERY  OF THIS  PROSPECTUS  NOR ANY SALE  MADE  HEREUNDER  SHALL,  UNDER  ANY
CIRCUMSTANCES,  CREATE ANY IMPLICATION THAT ANY INFORMATION  CONTAINED HEREIN IS
CORRECT AS OF ANY TIME SUBSEQUENT TO THE DATE HEREOF.



                              AVAILABLE INFORMATION

     The Company  files  reports,  proxy and  information  statements  and other
information with the Securities and Exchange Commission (the "Commission"). Such
reports,  statements  and  other  information  filed  by the  Company  with  the
Commission  can be  inspected  and  copied at the  public  reference  facilities
maintained  by the  Commission  at  Judiciary  Plaza,  450 Fifth  Street,  N.W.,
Washington,  D.C. 20549 and at the following Regional Offices of the Commission:
7 World Trade Center, Suite 1300, New York, New York 10048; and Citicorp Center,
500 West Madison Street,  Suite 1400, Chicago,  Illinois  60661-2511.  Copies of
such  material  can also be obtained  from the Public  Reference  Section of the
Commission at Judiciary Plaza, 450 Fifth Street, N.W., Washington, D.C. 20549 at
prescribed rates. Furthermore, the Commission maintains a Web site that contains
reports,  proxy and information  statements and other information  regarding the
Company. The address of such Web site is http://www.sec.gov.




                                        2

<PAGE>



                 INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

     The  documents  listed  below  have  been  filed  by the  Company  with the
Commission  under the  Securities  Exchange  Act of 1934,  as amended (the "1934
Act") and are incorporated herein by reference:

          (a) The  Company's  Annual  Report on Form  10-KSB for the fiscal year
     ended May 31, 1996, as amended (the "Form 10-KSB").

          (b) The Company's Quarterly Report on Form 10-QSB for the period ended
     August 31, 1996, as amended.

   
          (c) The Company's Quarterly Report on Form 10-QSB for the period ended
     November 30, 1996, as amended.

          (d) The Company's Quarterly Report on Form 10-QSB for the period ended
     February 28, 1997 (the "February 10-QSB").

          (e) The  description  of the Company's  Common Stock  contained in the
     Company's Registration Statement on Form 8(a), as amended.
    

     All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 or
15(d)  of the 1934  Act  after  the  date of this  Prospectus  and  prior to the
termination  of the offering of the Shares  offered hereby shall be deemed to be
incorporated  by  reference  into this  Prospectus  and to be a part hereof from
their respective dates of filing.

     The Company  will provide  without  charge to each person to whom a copy of
this  Prospectus  is  delivered,  upon the  written or oral  request of any such
person, a copy of any or all of the documents  referred to above which have been
incorporated  into this  Prospectus  by reference  (other than  exhibits to such
documents).  Requests  for such  copies  should be  directed  to the  Secretary,
Sandata, Inc., 26 Harbor Park Drive, Port Washington,  New York 11050 (telephone
number: (516) 484-9060).

     Any  statement  contained  in a document  incorporated  herein by reference
shall be deemed to be modified or superseded for purposes of this  Prospectus to
the extent  that a  statement  contained  herein  modifies  or  supersedes  such
statement.  Any statement so modified or superseded shall not be deemed,  except
as so modified or superseded, to constitute a part of this Prospectus.

                                   THE COMPANY

   
     The  Company,  through  its  wholly-owned  subsidiaries,  is engaged in the
business of providing  computerized data processing services and custom software
and programming services, by utilizing Company- developed software, and software
acquired or licensed by the Company,  principally  to the health care  industry,
but also to the general  commercial  market.  In addition,  the Company provides
hardware  maintenance of personal computers  ("PCs"),  printers and networks and
training on PC software packages.
    

                                        3

<PAGE>




     Applications of the Company's  software include: a home health care system,
computerized   preparation  of  management   reports,   payroll  processing  and
electronic  time card with voice  recognition  systems.  Principal  products and
services provided by the Company include the Sandsport Home Attendant  Reporting
Program,  data entry services and specialized system development,  among others.
In addition, the Company provides  administration and processing services for an
affiliate engaged in the pharmacy prescription  reimbursement business See "Risk
Factors--Unascertainable Risks Related to Possible Acquisitions".

     Generally,  in  providing  data  processing  services,  the  Company  first
receives data from its customers,  then processes it and generates reports based
on such data.  Services are provided to customers by processing on the Company's
equipment at its premises. The Company also has available software which permits
information  retrieval from customers'  facilities  which  communicate  with the
Company's  computers at its data center.  This allows the Company's customers to
have access to processing hardware and software without a substantial investment
on their part. The Company also offers its services on a turnkey basis.  Turnkey
computer  systems offer the customer  total  in-house  capabilities  through the
licensing  of the  Company's  software  for use on a  customer's  computer.  The
Company's  software  is  written in a variety of  software  languages  including
COBOL, C and FoxPro.

   
     Over the past several years, the Company has developed its Santrax product,
a  computerized  time and  attendance  management  system.  The  Santrax  system
utilizes voice  recognition and  telecommunications  technology to verify that a
person is at a particular telephone number at a particular time. Presently,  the
system is being  utilized by several of the Company's  home health care clients,
with the Company receiving approximately an aggregate of 400,000 calls per week.
Although no assurances can be given, it is anticipated  that the Santrax product
can be utilized by other industry  applications.  On April 10, 1997, the Company
received notice that MCI Telecommunications Corporation ("MCI") had commenced an
action against it in the United States  District Court for the Eastern  District
of New York  alleging  that the  Company's  Santrax time and  attendance  system
infringes on certain patent rights  allegedly owned by plaintiff.  The complaint
seeks  compensatory and treble damages with interest and injunctive  relief. The
Company  believes  that its product does not infringe on such patent  rights and
intends to vigorously  defend this action.  However,  in that the litigation has
only recently been commenced,  no assurances as to the outcome can be given. See
"Risk Factors--Proprietary Rights; Pending Litigation".
    

     The  Company  was  incorporated  in the  State of New York in June 1978 and
reincorporated  in the State of Delaware in December 1986, at which time it also
assumed its present name.

     The Company  maintains its executive  offices at 26 Harbor Park Drive, Port
Washington, New York 11050; telephone number (516) 484-9060.

                           FORWARD-LOOKING STATEMENTS

     The Company cautions readers that certain  important factors may affect the
Company's actual results and could cause such results to differ  materially from
any  forward-looking  statements  which  may be deemed to have been made in this
Prospectus or which are otherwise made by or on behalf of the Company.  For this
purpose,  any statements contained in this Prospectus that are not statements of
historical  fact  may be  deemed  to be  forward-  looking  statements.  Without
limiting the generality of the foregoing, words such as "may", "will", "expect",

                                        4

<PAGE>



     "believe",  "anticipate",  "intend", "could",  "estimate", or "continue" or
the  negative  variations  thereof or  comparable  terminology  are  intended to
identify  forward-looking  statements.  Factors  which may effect the  Company's
results include, but are not limited to, the risks and uncertainties  associated
with data  processing  and system  sales.  The Company is also  subject to other
risks detailed herein or detailed from time to time in the Company's  Commission
filings.  Factors that could cause or contribute to such difference include, but
are not limited to, those  discussed in "Risk Factors"  below,  as well as those
discussed  elsewhere in this  Prospectus  and in the Company's  filings with the
Commission.

                                  RISK FACTORS

     An investment in the securities  offered hereby is speculative and involves
a high degree of risk and should only be purchased  by investors  who can afford
to lose their  entire  investment.  Prospective  purchasers,  prior to making an
investment,  should  carefully  consider  the  following  risks and  speculative
factors, as well as other information set forth elsewhere in this Prospectus. As
discussed   above,   this  Prospectus   contains,   in  addition  to  historical
information,  forward-looking  statements that involve risks and  uncertainties.
The Company's actual results could differ  materially.  Factors that could cause
or  contribute  to  such  difference  include,  but are not  limited  to,  those
discussed below, as well as those discussed elsewhere in this Prospectus.


     1. Dependence on Governmental Program.

   
          For its fiscal years ended May 31, 1996 and 1995,  and the fiscal nine
     month periods ended February 28, 1997 and 1996, approximately 51%, 61%, 76%
     and 67%,  respectively,  of the  Company's  revenues were derived from data
     processing  and other related  services  rendered to vendor  agencies under
     contract with the Human  Resources  Agency of the City of New York ("HRA").
     Such vendor agencies receive a substantial portion of their operating funds
     from the federal  government  through its Medicaid program;  the balance of
     their  funding is  provided  by the State and City of New York.  Management
     believes that operations will, for the foreseeable  future,  continue to be
     dependent upon revenues generated from such vendor agencies. Elimination of
     the home attendant services program by HRA or a substantial cut-back in the
     level of funding of this program by the federal,  state or city governments
     would have, through the impact of such cut-backs on the vendor agencies,  a
     material  adverse  effect  on the  Company.  See  "Item  1--Description  of
     Business--Principal Products and Services" in the Form 10-KSB.
    

     2. Technological Obsolescence.

          The data processing and computer  software fields are characterized by
     rapid technological  developments and advances,  often resulting in partial
     or total obsolescence of systems.  There is no assurance that the Company's
     research and  development  activities will permit it to keep abreast of new
     developments.   See  "Item   1--Description   of   Business--Research   and
     Development" in the Form 10-KSB.



                                        5

<PAGE>



     3. Competition.

          Some  of  the  Company's  competitors  are  larger  and  have  greater
     financial resources than the Company.  Furthermore, the Company's customers
     may find it desirable to perform for themselves the services being rendered
     by  the  Company.   The  Company  also  competes  with  larger  and  better
     established  companies for the hiring of qualified  technical and marketing
     personnel. See "Item 1--Description of  Business--Competition"  in the Form
     10-KSB.

     4. Proprietary Rights; Pending Litigation.

   
          The Company does not own, nor has it applied  for,  Federal  Copyright
     registration  on its  computer  software  systems now in existence or being
     developed. However, the Company believes that its computer software systems
     are   proprietary   trade   secrets  and  that  they,   together  with  the
     documentation,  manuals,  training aids,  instructions  and other materials
     supplied by the Company to customers, are subject to the proprietary rights
     of the Company and protected by applicable  law.  However,  there can be no
     assurance  that  the  Company  will  be  able  to  protect  itself  against
     misappropriation  of its  proprietary  rights and trade secrets.  See "Item
     1--Business--Proprietary Rights" in the Form 10-KSB. On April 10, 1997, the
     Company  received notice that MCI had commenced an action against it in the
     United States District Court for the Eastern  District of New York alleging
     that the Company's  Santrax time and attendance system infringes on certain
     patent  rights   allegedly   owned  by  plaintiff.   The  complaint   seeks
     compensatory  and treble damages with interest and injunctive  relief.  The
     Company  believes  that its product does not infringe on such patent rights
     and  intends  to  vigorously  defend  this  action.  However,  in that  the
     litigation  has only  recently  been  commenced,  no  assurances  as to the
     outcome can be given.
    

     5. Control by Current Stockholders.

          The  Company's  Certificate  of  Incorporation  does not  provide  for
     cumulative voting.  Therefore,  stockholders owning in excess of 50% of the
     outstanding  shares of the Company's Common Stock are able to elect all the
     members  of the  Board of  Directors.  As of the  date of this  Prospectus,
     present  management of the Company owns  approximately  68.1% of the issued
     and  outstanding  shares of Common Stock of the Company and will be able to
     elect all of the Company's  directors and to control the Company.  However,
     upon the  completion of this  offering,  as to which no  assurances  can be
     made, the present management of the Company will own 13.2% in the aggregate
     of the issued and outstanding shares of the Company's Common Stock.

     6. Effect of Outstanding Exercisable Securities.

          As  of  the  date  of  this  Prospectus,  the  Company  had  currently
     exercisable  outstanding  options and  warrants  to purchase  shares of the
     Company's  Common Stock  exercisable at various prices from $1.38 to $7.00,
     subject  to  adjustment  per  share,  pursuant  to  which an  aggregate  of
     1,575,259  shares of Common Stock  (subject to  adjustment)  may be issued.
     This  includes  warrants  granted to the  Company's  Chairman  and  options
     granted to various directors, officers, employees and consultants.

          During the respective  terms of the Company's  outstanding  derivative
     securities,  the holders  thereof may be able to purchase  shares of Common
     Stock at prices substantially below the then-current market price of the

                                        6

<PAGE>



          Company's  Common Stock with a resultant  dilution in the interests of
     the  existing  stockholders.  In  addition,  the  exercise  of  outstanding
     derivative  securities and the  subsequent  public sales of Common Stock by
     holders  of such  securities  pursuant  to this  offering,  a  registration
     statement effected at their demand, under Rule 144 or otherwise, could have
     an  adverse  effect  upon  the  market  for  and  price  of  the  Company's
     securities.

     7. Shares Eligible for Future Sale May Adversely Affect the Market.

   
          870,420  of  the  Company's   outstanding   shares  of  Common  Stock)
     (exclusive  of  shares  of  Common  Stock  issuable  upon the  exercise  of
     outstanding  options and warrants) are "restricted  securities" and, in the
     future,  may  be  sold  upon  compliance  with  Rule  144  or  pursuant  to
     registration  (effected  by  demand  or other  rights  granted  to  certain
     stockholders)  under the Securities  Act. Rule 144 currently  provides,  in
     essence, that a person holding "restricted  securities" for a period of two
     years (as of April 29,  1997,  one  year)  may sell an amount  every  three
     months up to the greater of (a) 1% of the Company's  issued and outstanding
     securities of that class of securities or (b) the average  weekly volume of
     sales of such securities  during the four calendar weeks preceding the sale
     if there is adequate current public  information  available  concerning the
     Company. Additionally,  non-affiliates (who have not been affiliates of the
     Company for at least three months) may sell their  "restricted  securities"
     in compliance with Rule 144 without volume limitations after they have held
     such  securities  for a period of three  years (as of April 29,  1997,  two
     years).  An aggregate of 442,754  shares of Common Stock have been owned by
     Messrs.  Brodsky, Freund and Stoller for more than two years. However, such
     shares  are  subject to an  agreement  with  Barber & Bronson  Incorporated
     ("B&B")  imposing  certain  restrictions  on the public sale thereof  until
     December  22,  1997  without  B&B's  consent.  B&B has  authorized  Messrs.
     Brodsky, Freund and Stoller to sell an aggregate of 1,238,140 shares, which
     amount  includes  outstanding  shares of Common Stock, as well as shares of
     Common Stock underlying presently exercisable options and warrants.
    

          The Company is registering for resale 1,988,140 Shares held by certain
     stockholders,  including,  without  limitation,  Shares underlying  certain
     options and warrants.  Such Shares may be resold at any time  following the
     date of this  Prospectus.  Prospective  investors  should be aware that the
     possibility  of  resales  by the  Selling  Stockholders,  as well as  other
     stockholders of the Company,  may have a material  depressive effect on the
     market  price of the  Company's  shares of Common Stock in any market which
     may develop.

          8.  Ability  to  Renew  Present  Financing;   Significant  Outstanding
     Indebtedness; Loan Covenants and Security Interests.

   
          From time to time the Company  and/or its  subsidiaries  have  entered
     into loan arrangements with Marine Midland Bank (the "Bank"), among others.
     As of February 28, 1997, the Company owed the Bank $237,486.

          On April 18, 1997, the Company's  wholly owned  subsidiary,  Sandsport
     Data Services, Inc. ("Sandsport") entered into a Revolving Credit Agreement
     (the "Credit Agreement") with the Bank which allows Sandsport to borrow and
     re-borrow amounts up to $3,000,000. Interest accrues on amounts outstanding
     under the Credit Agreement at a rate equal to the London Interbank  Offered
     Rate plus 2% and will be paid  quarterly  in  arrears  or,  at  Sandsport's
     option,  interest may accrue at the Bank's prime rate. The Credit Agreement
     required  Sandsport to pay a commitment  fee in the amount of $30,000 and a
     fee equal to 1/4% per annum  payable on the unused  average  daily
     balance of amounts under the Credit Agreement. In addition, there are other
     fees and charges imposed
    

                                                                 7

<PAGE>



   
          based upon Sandsport's  failure to maintain certain minimum  balances.
     The Credit Agreement will expire on March 1, 2000. The  indebtedness  under
     the Credit  Agreement is guaranteed by the Company and  Sandsport's  sister
     subsidiaries (the "Group"). The collateral for the facility is a first lien
     on all  equipment  owned  by  Sandsport  and the  guarantors,  as well as a
     collateral  assignment of $2,000,000 of life insurance  payable on the life
     of Mr.  Brodsky.  The Group's  guaranty to the Bank,  relating to the bonds
     discussed below,  was modified to conform  covenants  described  therein to
     comply with those in the Credit Agreement.

          All of the Group assets are pledged to the Bank as collateral  for the
     amounts  due under the  Credit  Agreement.  The  Group is  prohibited  from
     incurring additional indebtedness except under certain circumstances.

          In addition,  pursuant to the Credit Agreement,  the Group is required
     to maintain  certain levels of net worth and meet certain  financial ratios
     in addition to various other affirmative and negative covenants.  The Group
     has, in the past, under prior agreements with the the Bank,  failed to meet
     these net worth and  financial  ratios,  and the Bank has granted the Group
     waivers.  No  assurance  can be given  that the Group  will be able to meet
     these net worth and financial  requirements in the future,  and/or that the
     Bank will continue to grant to the Group waivers.  Although in the past the
     Bank has renewed its loans to the Company when they  matured,  there can be
     no assurance  that it will  continue to do so or that the  Company,  if the
     Bank does not renew the loan, will be able to arrange alternative financing
     on terms satisfactory to it.

          In addition,  the Company is indebted to companies affiliated with the
     Company's  Chairman in the amount,  as of February 28, 1997, of $1,297,000.
     Of this  amount,  as of February  28,  1997,  an  aggregate  of $462,000 of
     indebtedness was evidenced by notes due in December 1997 and May 1998.
    

          On June 1, 1994,  BFS Sibling  Realty Inc.,  formerly known as Brodsky
     Sibling Realty,  Inc. ("BFS") borrowed $3,350,000 in the form of Industrial
     Development Revenue Bonds ("Bonds") to finance costs incurred in connection
     with the  acquisition,  renovation  and equipping of the  Company's  office
     space  located at 26 Harbor  Park  Drive,  Port  Washington,  New York (the
     "Facility" or the "Building") from the Nassau County Industrial Development
     Agency (the "NCIDA").  These Bonds were subsequently purchased by the Bank.
     The aggregate  cost incurred by BFS in conjunction  with such  acquisition,
     renovation and equipping was  approximately  $4,377,000.  In addition,  the
     Company  incurred  approximately  $500,000 of indebtedness to affiliates of
     Mr. Brodsky in connection with additional capital  improvements.  The Bonds
     bore  interest at prime plus 3/4 of 1% until August 11, 1995, at which time
     the interest rate became fixed at 9% for a five-year term through September
     1, 2000.  At that time,  the  interest  rate will be  adjusted to a rate of
     either prime plus 3/4 of 1%, or the applicable fixed rate if offered by the
     Bank. As a condition to the issuance of the Bonds, the NCIDA obtained title
     to the  Facility  which it then leased to BFS. On June 21, 1994 (as of June
     1,  1994),  the  Company and its  Chairman  guaranteed  the full and prompt
     payment of principal and interest of the Bonds and the Company  granted the
     Bank a  security  interest  and lien on all the assets of the  Company.  In
     connection  with the  issuance and sale of the Bonds,  the Company  entered
     into a lease  agreement  (the  "Sublease")  with BFS,  whereby  the Company
     leased the Facility for the conduct of its business  and, in  consideration
     therefor,  was obligated to make lease payments that at least equal amounts
     due to satisfy the underlying Bond obligations.

          On July 31, 1995, by an Assignment and Assumption and First  Amendment
     to Lease between the Company and BFS, the Company  assumed the  obligations
     of BFS under the lease and became the direct tenant and

                                        8

<PAGE>



          the beneficial  owner of the Facility  (collectively  the  "Assignment
     Transaction").  In connection with the Assignment Transaction, the Sublease
     was  terminated.  During  the  period  commencing  July 1, 1995 and  ending
     October 31, 1996 the Company paid rent for the Facility to the NCIDA in the
     amount of $48,600  per month,  subject  to  adjustment  based upon the then
     effective  interest rate of the Bonds,  among other  things.  In connection
     with the Assignment Transaction,  the Company obtained the right to acquire
     the Facility upon  expiration of the lease with the NCIDA (the "Lease") and
     became  directly  liable  to the  NCIDA  for  amounts  due  thereunder.  In
     connection  with the Assignment  Transaction,  the Company  assumed certain
     indebtedness owed to affiliates of the Company's  Chairman as follows:  (i)
     the $364,570  remaining balance of a 48-month term loan bearing interest at
     8.7% per annum, and (ii) the $428,570  remaining balance of a 42-month term
     loan bearing  interest at 8.91%.  Each of the foregoing loans were incurred
     in connection with the  construction  of improvements to the Building,  are
     collateralized  by the assets of the primary  obligor and are guaranteed by
     the Company's Chairman.

          On August 11, 1995, the Company entered into a $750,000 loan agreement
     with the Long Island Development Corporation ("LIDC"), under a guarantee by
     the U.S. Small Business Administration ("SBA") (the "SBA Loan"). The entire
     $750,000  proceeds  have  been used to repay a portion  of the  Bonds.  The
     Company  entered  into the  Assignment  Transaction  primarily  to  satisfy
     certain  requirements  of the SBA.  The SBA Loan is payable in 240  monthly
     installments of $6,255,  which includes principal and interest at a rate of
     7.015%.

          As of November 1, 1996,  the Company  entered into an  Assignment  and
     Assumption  of and Second  Amendment to Lease  Agreement  among BFS Realty,
     LLC, an affiliate of the Company's Directors (the "Assignee"), the Bank and
     the  Company  (the  "Second  Amendment").  In  connection  with the  Second
     Amendment,  (i) the Assignee assumed all of the Company's obligations under
     the Lease with the NCIDA and entered  into a sublease  with the Company for
     the  Facility;  and (ii) the Company  conveyed to the Assignee the right to
     become the owner of the Facility upon expiration of the Lease. In addition,
     pursuant to the sublease,  the Company has assumed certain obligations owed
     by the Assignee to the NCIDA under the Lease.  The Assignee has indemnified
     the Company with respect to certain  obligations  relative to the Lease and
     the Second Amendment.

          The documentation with regard to each of the foregoing contain various
     covenants  requiring  and/or  restricting  the Company from taking  various
     action.  Among other  things,  the  documentation  relating to the SBA Loan
     contains certain covenants which require certain principal  stockholders of
     the  Company to  maintain  certain  levels of equity in the  Company.  Such
     restriction  could  impact  the  Company's  ability  to  engage  in  equity
     financings and a violation of such covenant could result in a default under
     the SBA Loan. In the past,  the Company has been able to obtain a waiver of
     such provision, however, no assurances can be made that it will continue to
     be able to do so.  Messrs.  Brodsky,  Freund and Stoller  have  advised the
     Company  that,  if as a result  of action  taken by any of them,  a default
     occurs under the SBA Loan, such individuals shall either cure such default,
     if possible, or satisfy the obligation.

     10. Limited Marketing Capability.

          The Company has limited marketing capabilities and resources. To date,
     substantially  all of the Company's  commercial  marketing  activities have
     been conducted by sales  representatives  directly  employed by the Company
     and independent sales agents.  Such activities have consisted  primarily of
     personal  contact with  potential  customers.  Because of the nature of the
     Company's business, management will continue to devote a substantial

                                        9

<PAGE>



          amount  of  time  developing  and  maintaining   continuing   personal
     relationships  with the Company's  customers.  See "Item  1--Description of
     Business--Marketing and Distribution" in the Form 10-KSB.

     11. Dependence on Key Personnel.

          The Company is dependent upon the expertise and abilities of three key
     executive personnel:  Bert E. Brodsky, Chairman of the Board, President and
     Treasurer,  Hugh Freund,  Executive Vice President and Secretary,  and Gary
     Stoller,  Executive  Vice  President.  Messrs.  Stoller  and Freund are not
     parties to any employment  agreements with the Company;  Effective February
     1, 1997 the Company and Mr.  Brodsky  entered into an employment  agreement
     for a 5 year term (the "Brodsky Employment Agreement"). Among other things,
     the Brodsky  Employment  Agreement  provides for compensation at the annual
     rate of $500,000.  See--"Subsequent  Events".  The Company's agreement with
     the  Bank  requires  that  Mr.   Brodsky  at  all  times  be  active  on  a
     substantially full-time basis in the affairs of the Company. The Company or
     its  subsidiaries is the beneficiary  under certain key- man life insurance
     policies  on the life of each of Messrs.  Brodsky and Freund in the amounts
     of  $4,500,000  and  $1,400,000,  respectively,  the  benefits of which are
     payable  to the  Company.  Of such  insurance  benefits,  an  aggregate  of
     $2,000,000  on the  life of Mr.  Brodsky  has  been  pledged  to the  Bank.
     However,  if the  Company  were to lose the  services  of any of these  key
     personnel as a result of  disability,  death or otherwise the Company could
     be in default under its agreement  with the Bank and its business  could be
     adversely affected.

     12. No Dividends.

          To date,  the  Company has not paid any cash  dividends  on its Common
     Stock and does not expect to declare or pay any cash or other  dividends in
     the foreseeable  future.  Dividends are restricted pursuant to the terms of
     the Credit Agreement between the Company and the Bank. See "Item 5 - Market
     for Common Equity and Related Stockholder  Matters--Dividend Policy" in the
     Form 10-KSB.

          13.  Unascertainable  Risks  Related  to  Possible  Acquisitions.  The
     Company intends to explore  opportunities  to add,  through  acquisition or
     licensing,  technology or products to enhance or add to its current product
     line,  or to acquire a customer base or sales  organization  to augment the
     Company's infrastructure.  In exploring potential acquisitions or licenses,
     the Company will consider,  among other criteria:  the comparative  cost to
     the Company in capital,  resources and  personnel to create the  identified
     technology or product,  or to establish the targeted customer base or sales
     organization;  restrictions to the Company developing similar technology or
     products arising from patent or other intellectual property protection; and
     the synergy of the identified  technology or products,  or customer base or
     sales organization, with the Company's products and organization.  Although
     the Company  anticipates it will follow the foregoing  general  criteria in
     determining  whether or not to make any acquisitions,  management will have
     sole discretion over whether or not to engage in an acquisition.  There can
     be no assurance that the Company will identify any acquisition or licensing
     candidates or, if it does,  that it will be able to reach any agreements to
     acquire or license  technology  or products,  or acquire  assets,  on terms
     acceptable  to the  Company.  To the  extent  that the  Company  effects an
     acquisition  of technology or products in the early stage of development or
     growth  (including  technology or products which have not been fully tested
     or  marketed),  the Company will be subject to numerous  risks  inherent in
     developmental  technology and other high level of risk associated with high
     technology  industries  based  on  innovative  technologies  or  processes.
     Furthermore,  future  acquisition  transactions  may require the Company to
     obtain additional financing from banks or financial institutions

                                       10

<PAGE>



          or to undertake  debt or equity  financing.  No assurance can be given
     that  the  Company  would be able to  obtain  financing  upon  commercially
     reasonable terms, or at all. Furthermore, equity financing will result in a
     dilution of existing Stockholders of the Company, which may be significant.
     To the extent that debt financing  ultimately  proves to be available,  any
     borrowings   may  subject  the  Company  to  various  risks   traditionally
     associated  with the  incurring  of  indebtedness,  including  the risks of
     interest rate  fluctuations and insufficiency of cash flow to pay principal
     and  interest.  Although  the Company  will  endeavor to evaluate the risks
     inherent in a particular  acquisition,  there can be no assurance  that the
     Company will properly ascertain or assess such significant risk factors.

          The Company  provides data  processing  services to a company of which
     affiliates of Mr. Brodsky are principal stockholders,  and which is engaged
     in the administration of pharmacy prescription  reimbursement  programs for
     unions and other benefit  providers.  The Company is  considering  entering
     into  the  pharmacy  prescription  reimbursement   administration  business
     directly  or  through  one or  more  acquisitions  of  existing  companies,
     including,  without limitation,  the above mentioned affiliate; the Company
     is considering  several possible  acquisition  candidates in such industry,
     including, without limitation, the above-mentioned affiliate;  however, the
     Company is in the preliminary  stages of such consideration and has not had
     formal negotiations with any such company.  Accordingly,  no assurances can
     be  made as to  whether  (i) the  Company  will  enter  into  the  business
     directly,  (ii) any of the acquisitions  presently being considered will be
     consummated,   (iii)  if  consummated,   the  terms  upon  which  any  such
     acquisitions may occur, and (iv) if consummated,  whether such acquisitions
     will be  successful.  Except  as set  forth  above,  as of the date of this
     Prospectus  , the  Company  has no other  specific  plans  with  respect to
     material acquisitions.  In addition to the foregoing, the Company may, from
     time to time, enter into agreements with related parties. In such case, the
     Company  anticipates that the terms of such agreements will be commercially
     reasonable  and no less  favorable  to the Company  than the Company  could
     obtain from unrelated third parties. Additionally, the Company intends that
     such agreements will be approved by a majority of disinterested directors.

     14. Securities Market Factors.

          In recent years, the securities  markets have experienced a high level
     of volume  volatility  and market prices for many  companies,  particularly
     small and emerging growth companies, have been subject to wide fluctuations
     in response to quarterly variations in operating results. The securities of
     many of theses companies which trade in the  over-the-counter  market, have
     experienced wide price fluctuations,  which in many cases were unrelated to
     the operating performance of, or announcements  concerning,  the issuers of
     the affected  stock.  Factors such as  announcements  by the Company or its
     competitors   concerning   technological   innovations,   new  products  or
     procedures, government regulations and developments or disputes relating to
     proprietary  rights  may have a  significant  impact on the  market for the
     Company's securities. General market price declines or market volatility in
     the  future  could  adversely  affect  the  future  price of the  Company's
     securities.

   
     15. Prior Public Announcements.

          In a January 20, 1997 Newsday article,  Mr. Brodsky was referred to as
     saying that the Company  could have  revenues "in excess of 12 million" for
     the fiscal year ended May 31, 1997. As of the date of this Prospectus,  the
     Company  anticipates  that  revenue  for the fiscal year ended May 31, 1997
     will likely be between $11 million and $12 million,  and though not likely,
     could exceed $12 million if the fourth quarter is particularly  strong,  as
     to  which  no  assurances  can  be  made.   The  foregoing   constitutes  a
     forward-looking statement as to which no
    

                                       11

<PAGE>



          assurances can be given with respect to the outcome  thereof.  Factors
     making it problematic to determine the outcome of the foregoing  statements
     include,  among other things, general market and economic factors affecting
     the Company's  sales in the fourth quarter of the fiscal year ended May 31,
     1997.

                                SUBSEQUENT EVENTS

     Effective  February 1, 1997, the Company and Mr.  Brodsky  entered into the
Brodsky Employment Agreement providing for, among other things,  compensation at
the annual rate of $500,000  plus such bonuses or additional  compensation  that
the Board of Directors of the Company may, on the basis of  improvements  in the
Company's performance or other reasonable criteria, deem appropriate. During the
term of the Brodsky  Employment  Agreement,  the employee shall also be provided
with a  full-time  use of a  Company  automobile,  six (6) weeks  paid  vacation
annually and group medical  insurance and other  benefits or programs  which the
Company establishes or is made available to its employees.

   
     In March 1997,  Sandsport entered into a  sale/lease-back  transaction with
General  Electric  Capital  Corporation  ("GEC")  whereby  certain fixed assets,
including,  without  limitation,  a certain  program  licensing  agreement  (the
"License") (the "Assets"), were sold to GEC for $981,000 and concurrently leased
back to  Sandsport.  The  License  was  originally  paid  for by  Sandsport  and
inadvertently  registered  in the name of an affiliate of Mr.  Brodsky for which
the Company provides services,  but was assigned to Sandsport in connection with
the  above-mentioned  lease.  The lease  requires  monthly  rental  payments  of
$25,465.98  commencing  on May 1,  1997 for a term of 38  months,  and  provides
Sandsport the option to purchase the Assets for $200,000 upon  expiration of the
lease.  Sandsport has assigned such purchase  option to P.W.  Capital Corp.,  an
affiliate of the  Company's  Chairman  ("PW"),  which has agreed to purchase the
Assets  from GEC  subject  to the  terms of the lease. PW acquired  the right to
purchase such  equipment on  consideration  of its posting a letter of credit in
connection with such lease.
    


                              SELLING STOCKHOLDERS

   
     The  following  table sets forth,  as of April 24, 1997,  to the  Company's
knowledge,  certain securities ownership information with respect to the Selling
Stockholders:
<TABLE>
<CAPTION>
    




                                 Common Shares                Number of Common              Common Shares to be
                                 Beneficially                    Shares Offered              Beneficially Owned
Name and Address                    Owned (1)                      for Sale                    After Offering(2)
- ---------------                    ---------                      --------                    --------------   

                                                                                                Number     Percent of Outstanding
<S>                              <C>                            <C>                            <C>              <C>      
Bert E. Brodsky                  955,809 (3)                    820,213 (3)                    135,596      7.1%
Hugh Freund                      323,493 (4)                    255,696 (4)                    67,797       5.0%
Gary Stoller                     257,786 (5)                    162,231 (5)                    95,555       7.2%


                                       12

<PAGE>




                                  Common Shares                Number of Common              Common Shares to be
                                  Beneficially                    Shares Offered              Beneficially Owned
Name and Address                    Owned (1)                      for Sale                    After Offering(2)
- ----------------                    ---------                      --------                    --------------   
                                                                                                                Percent of
                                                                                               Number           Outstanding
Steven N. Bronson                152,950 (6)                    152,950 (6)                    -0-          -0-
James S. Cassel                  30,800 (7)                     30,800 (7)                     -0-          -0-
James S. Cassel and Mindy
 Cassel, TBTE                    58,300 (8)                     58,300 (8)                     -0-          -0-
James S. Cassel, as
Custodian for Chira Cassel       1,000                          1,000                          -0-          -0-
James S. Cassel, as
Custodian for Seth Cassel
under the Uniform Gifts to
Minors Act ("UGMA") 1996         1,000                          1,000                          -0-          -0-
James S. Cassel, as
Custodian for Philip Cassel
under the Uniform Gifts to
Minors Act 1996                  1,000                          1,000                          -0-          -0-
James S. Cassel, as
Custodian for Levi Cassel
under the Uniform Gifts to
Minors Act 1996                  1,000                          1,000                          -0-          -0-
Keil Stern                       30,000 (9)                     30,000 (9)                     -0-          -0-
Eric R. Elliot                   8,900 (10)                     6,650 (10)                     -0-          -0-
Eric R. Elliott (IRA)            7,500 (15)                     7,500 (15)                     -0-          -0-
Barry J. Booth                   6,650 (11)                     6,650 (11)                     -0-          -0-
Bruce C. Barber                  6,650 (12)                     6,650 (12)                     -0-          -0-
Barry Steiner & Lisa Steiner
(JT)                             5,750 (13)                     5,750 (13)                     -0-          -0-
Scott Salpeter                   2,000 (14)                     2,000 (14)                     -0-          -0-
Leonard Adler                    3,750 (15)                     3,750 (15)                      -0-         -0-
Hans Koenig Revocable
Living Trust
(Hans & Hanni Koenig) - by
agreement 3/6/91                 7,500 (15)                     7,500 (15)                     -0-          -0


                                       13

<PAGE>




                                  Common Shares                Number of Common              Common Shares to be
                                  Beneficially                    Shares Offered              Beneficially Owned
Name and Address                    Owned (1)                      for Sale                    After Offering(2)
- ----------------                    ---------                      --------                    --------------   
                                                                                                                Percent of
                                                                                               Number           Outstanding
Paul Pesce                       7,500 (15)                     7,500 (15)                     -0-          -0-
Amral Raul Ragoonanan            3,750 (15)                     3,750 (15)                     -0-          -0-
Peter David Bronson &
Maguy F. Bronson (JT)            7,500 (15)                     7,500 (15)                     -0-          -0-
Martin & Dolores Elkin (JT)      7,500 (15)                     7,500 (15)                     -0-          -0-
Stephen Paul Kregstein           3,750 (15)                     3,750 (15)                     -0-          -0-
Juetten Family Trust
(Richard Juetten, Trustee) -
by agreement dated 4/4/91        3,750 (15)                     3,750 (15)                     -0-          -0-
Kenneth B. Elias                 3,750 (15)                     3,750 (15)                     -0-          -0-
Ronald A. David & Dona C.
David (TE)                       3,750 (15)                     3,750 (15)                     -0-          -0-
Haguy Shechter                   7,500 (15)                     7,500 (15)                     -0-          -0-
Nial Maura Ingerto               3,750 (15)                     3,750 (15)                     -0-          -0-
Ronald Richard Fieldstone &
Linda Brady Fieldstone (TE)      7,500 (15)                     7,500 (15)                     -0-          -0-
Gordon Jay Dow (IRA)             7,500 (15)                     7,500 (15)                     -0-          -0-
James Allen Settlage &
Carol Lynn Settlage (JT)         3,750 (15)                     3,750 (15)                     -0-          -0-
Paul Maurice Bronson &
Laura Mae Bronson (JT)           7,500 (15)                     7,500 (15)                     -0-          -0-
Fern Susan Thaw                  3,750 (15)                     3,750 (15)                     -0-          -0-
David Wayne Raisbeck &
Ellen Jane Raisbeck (JT)         3,750 (15)                     3,750 (15)                     -0-          -0-
The Petersen Family Trust
(Norman W. Petersen) - by
agreement 9/28/93                3,750 (15)                     3,750 (15)                     -0-          -0-
Margery Schwartz
(Cust for Evan Schwartz NJ-
UTMA)                            3,750 (15)                     3,750 (15)                     -0-          -0-


                                       14

<PAGE>




                                  Common Shares                Number of Common              Common Shares to be
                                  Beneficially                    Shares Offered              Beneficially Owned
Name and Address                    Owned (1)                      for Sale                    After Offering(2)
- ----------------                    ---------                      --------                    --------------   
                                                                                                                Percent of
                                                                                               Number           Outstanding
Joseph Anthony Spinella          3,750 (15)                     3,750 (15)                     -0-          -0-
David William Rogers             3,750 (15)                     3,750 (15)                     -0-          -0-
Craig Loren Silverman            3,750 (15)                     3,750 (15)                     -0-          -0-
Anthony Peter Conza              7,500 (15)                     7,500 (15)                     -0-          -0-
Jeffrey L. Thomas & Sylvia
H. Thomas (JT)                   3,750 (15)                     3,750 (15)                     -0-          -0-
Howard Clifford Beach            3,750 (15)                     3,750 (15)                     -0-          -0-
Delaware Charter Guarantee
& Trust Co.
Custodian  F/B/O Law
Offices Bruce Thaw Keogh
Plan                             3,750 (15)                     3,750 (15)                     -0-          -0-
Sylvia Levine                    3,750 (15)                     3,750 (15)                     -0-          -0-
Hal Kaufman                      3,750 (15)                     3,750 (15)                     -0-          -0-
Leonard Goodfriend &
Audrey Goodfriend (JT)           3,750 (15)                     3,750 (15)                     -0-          -0-
A.C. Brown                       3,750 (15)                     3,750 (15)                     -0-          -0-
Frederick H. Fialkow             7,500 (15)                     7,500 (15)                     -0-          -0-
James A. Cook                    3,750 (15)                     3,750 (15)                     -0-          -0-
Thomas A. Hanford Trust
(Thomas A. Hanford)        - by
agreement 5/17/96                7,500 (15)                     7,500 (15)                     -0-          -0-
S. Daniel Ponce (IRA)            3,750 (15)                     3,750 (15)                     -0-          -0-
Yehuda Shechter                  7,500 (15)                     7,500 (15)                     -0-          -0-
Effectenbank Stroeve N.V.        7,500 (15)                     7,500 (15)                     -0-          -0-
Jeffrey Scott Roschman           7,500 (15)                     7,500 (15)                     -0-          -0-
Steven I. Levin                  3,750 (15)                     3,750 (15)                     -0-          -0-
Frank T. Vicino, Jr.             3,750 (15)                     3,750 (15)                     -0-          -0-


                                       15

<PAGE>




                                   Common Shares                Number of Common              Common Shares to be
                                   Beneficially                    Shares Offered              Beneficially Owned
 Name and Address                    Owned (1)                      for Sale                    After Offering(2)
 ----------------                    ---------                      --------                    --------------   
                                                                                                                Percent of
                                                                                               Number           Outstanding
Mark S. Schecter                 3,750 (15)                     3,750 (15)                     -0-          -0-
Michael J. Bonner &
Deborah M. Bonner (JT)           3,750 (15)                     3,750 (15)                     -0-          -0-
C.G. Chase Construction Co.      7,500 (15)                     7,500 (15)                     -0-          -0-
John Raymond Prufeta             3,750 (15)                     3,750 (15)                     -0-          -0-
Richard S. Serbin & Kathe
Serbin                           7,500 (15)                     7,500 (15)                     -0-          -0-
Zvika Shechter                   3,750 (15)                     3,750 (15)                     -0-          -0-
George Andrew Solack             3,750 (15)                     3,750 (15)                     -0-          -0-
Sheldon Drobny                   7,500 (15)                     7,500 (15)                     -0-          -0-
Susan Lambeth Charitable
Remainder Unitrust
(Susan Lambeth and Edmuns
Schupp) - by agreement
3/5/47                           7,500 (15)                     7,500 (15)                     -0-          -0-
Mark Hart                        11,250 (15)                    11,250 (15)                    -0-          -0-
David Brian Cohen                7,500 (15)                     7,500 (15)                     -0-          -0-
Robert Stuart Pearlman &
Rita Jo Pearlman (JT)            3,750 (15)                     3,750 (15)                     -0-          -0-
Robbins, Tunkey, Ross,
Amsel, Raben and Waxman,
P.A.
401K Profit Sharing Trust
F/B/O William R. Tunkey          3,750 (15)                     3,750 (15)                     -0-          -0-
Doran Topaz                      3,750 (15)                     3,750 (15)                     -0-          -0-
Harvey Morton Soldan &
Ingrid Else Soldan (JT)          7,500 (15)                     7,500 (15)                     -0-          -0-
The Beckham Family Trust
(David Beckham, Trustee) -
by agreement dated 10/26/95      3,750 (15)                     3,750 (15)                     -0-          -0-
Boris Zalkind                    3,750 (15)                     3,750 (15)                     -0-          -0-


                                       16

<PAGE>




                                   Common Shares                Number of Common              Common Shares to be
                                   Beneficially                    Shares Offered              Beneficially Owned
Name and Address                    Owned (1)                      for Sale                    After Offering(2)
- ----------------                    ---------                      --------                    --------------   
                                                                                                                Percent of
                                                                                               Number           Outstanding
Eliahu Ben-Shmuel                7,500 (15)                     7,500 (15)                     -0-          -0-
Horst Siegfried Filtzer          3,750 (15)                     3,750 (15)                     -0-          -0-
Charles G. Leaness               3,750 (15)                     3,750 (15)                     -0-          -0-
Lior Ben-Shmuel                  7,500 (15)                     7,500 (15)                     -0-          -0-
Sonya Ben-Shmuel Personal
Revocable Trust (Sonya
Ben-Shmuel, Trustee) - by
agreement dated 5/13/96          3,750 (15)                     3,750 (15)                     -0-          -0-
The Equity Group Profit-
Sharing Plan and Trust
(Robert D. Goldstein,
Trustee) - by agreement
dated 1/1/80                     7,500 (15)                     7,500 (15)                     -0-          -0-
Jeffrey I. Binder & Rosalie
G. Binder (TE)                   7,500 (15)                     7,500 (15)                     -0-          -0-
Jay Haft                         3,750 (15)                     3,750 (15)                     -0-          -0-
Henry Tie Shue                   3,750 (15)                     3,750 (15)                     -0-          -0-
Bruno Guazzoni
c/o Zanett Capital, Inc.         7,500 (15)                     7,500 (15)                     -0-          -0-
Barry J. Booth & Suellen G.
Booth (JT)                       7,500 (15)                     7,500 (15)                     -0-          -0-
Lenore Katz                      7,500 (15)                     7,500 (15)                     -0-          -0-
Private Opportunity Partners
II, Ltd.
FL Limited Partnership           71,250                         71,250                         -0-          -0-
</TABLE>


(1)               Unless  otherwise noted, the Company believes that all persons
                  named above have sole voting and investment power with respect
                  to all Common  Stock  beneficially  owned by them,  subject to
                  community property laws, where applicable.  A person is deemed
                  to be the beneficial  owner of securities that can be acquired
                  by such  person  within 60 days from the date  hereof upon the
                  exercise  of  warrants or  options.  Each  beneficial  owner's
                  percentage ownership is determined by assuming that options or
                  warrants  that are held by such  person (but not those held by
                  any other  person)  and which are  exercisable  within 60 days
                  from the date hereof have been exercised.


                                       17

<PAGE>



(2)               Assumes that all of the shares registered for the account of 
                  the Selling Stockholders are sold.

(3)               Includes 50,000 shares of Common Stock owned by Mr.  Brodsky's
                  wife.  Includes  presently  exercisable  options  to  purchase
                  74,000  shares  of Common  Stock at $1.79 per share  under the
                  Company's   Employee's   Incentive   Stock  Option  Plan  (the
                  "Incentive Plan");  includes presently  exercisable options to
                  purchase  44,000  shares  of  Common  Stock at $1.51 per share
                  under the 1995 Stock Option Plan (the "1995  Plan");  includes
                  presently  exercisable  options to purchase  44,000  shares of
                  Common Stock at $2.34 per share under the 1995 Plan;  includes
                  presently  exercisable  options to purchase  60,667  shares of
                  Common Stock at $1.38 per share under the Non-Qualified  Stock
                  Option Plan (the  "Non-Qualified  Plan");  includes  presently
                  exercisable options to purchase 110,000 shares of Common Stock
                  at $2.61 per share  under the 1995  Plan;  includes  presently
                  exercisable  warrants  to  purchase  400,000  shares of Common
                  Stock at $1.38  per  share  under a  Warrant  Agreement  which
                  expires  in  August,  2001;  includes  68,352  shares  of  the
                  Company's Common Stock owned by the trusts established for the
                  benefit of Mr.  Brodsky's four children,  of which Mr. Brodsky
                  is a trustee.

(4)               Excludes  8,000 shares of Common  Stock owned by Mr.  Freund's
                  adult  children.  Excludes  4,000  shares of Common  Stock and
                  presently exercisable options to purchase (i) 43,000 shares of
                  Common Stock at $1.79 per share under the Incentive Plan, (ii)
                  18,000  shares  of Common  Stock at $1.38 per share  under the
                  1995 Plan and (iii)18,000  shares of Common Stock at $1.38 per
                  share under the Non-Qualified Plan owned by Mr. Freund's wife.
                  As set forth in Mr. Freund's  Schedule 13G, filed with the SEC
                  on February  9, 1997,  Mr.  Freund  disclaims  any  beneficial
                  interest  in, or  voting or  dispositive  control  over,  such
                  shares;  includes  presently  exercisable  options to purchase
                  43,000  shares  of Common  Stock at $1.79 per share  under the
                  Incentive  Plan;  includes  presently  exercisable  options to
                  purchase  18,000  shares  of  Common  Stock at $1.51 per share
                  under the 1995 Plan; includes presently exercisable options to
                  purchase  36,000  shares  of  Common  Stock at $2.34 per share
                  under the 1995 Plan; includes presently exercisable options to
                  purchase  18,000  shares  of  Common  Stock at $1.38 per share
                  under the Non-Qualified Plan;  includes presently  exercisable
                  options to purchase 90,000 shares of Common Stock at $2.61 per
                  share under the 1995 Plan.

(5)               Includes  presently  exercisable  options to  purchase  46,667
                  shares of Common Stock at $1.79 per share under the  Incentive
                  Plan;  includes  presently  exercisable  options  to  purchase
                  20,000  shares  of Common  Stock at $1.51 per share  under the
                  1995 Plan; includes presently  exercisable options to purchase
                  20,000  shares  of Common  Stock at $2.34 per share  under the
                  1995 Plan; includes presently  exercisable options to purchase
                  20,000  shares  of Common  Stock at $1.38 per share  under the
                  Non-Qualified Plan; includes presently  exercisable options to
                  purchase  50,000  shares  of  Common  Stock at $2.61 per share
                  under the 1995 Plan.  Includes  13,000 shares of the Company's
                  Common  Stock owned by trusts  established  for the benefit of
                  Mr. Stoller's children of which Mr. Stoller is a trustee.

(6)               Includes 101,200 Shares issuable upon the exercise of 
                  currently exercisable warrants.

(7)               Includes 30,800 Shares issuable upon the exercise of currently
                  exercisable warrants.

(8)               Includes 30,800 Shares issuable upon the exercise of currently
                  exercisable warrants.

(9)               Includes 20,000 Shares issuable upon the exercise of currently
                  exercisable warrants.

(10)              Includes 4,400 Shares issuable upon the exercise of currently 
                  exercisable warrants.

(11)              Includes  4,400 Shares issuable upon the exercise of currently
                  exercisable warrants.

(12)              Includes 4,400 Shares issuable upon the exercise of currently 
                  exercisable warrants.

(13)              Includes 2,000 Shares issuable upon the exercise of currently 
                  exercisable warrants.

(14)              Includes 2,000 Shares issuable upon the exercise of currently 
                  exercisable warrants.


                                       18

<PAGE>



(15)              Of such amount, two-thirds represents shares of Common Stock 
                  and one-third represents shares of Common Stock issuable upon 
                  exercise of currently exercisable warrants.

     Certain of the securities set forth in the above table are included in this
Prospectus  pursuant  to  registration  commitments  accorded  to certain of the
Selling  Stockholders.  There are no  commitments  pursuant to which the Company
will  receive  any  proceeds  from  the  sale  of  the  Shares  by  the  Selling
Stockholders.

     To the Company's  knowledge,  no Selling  Stockholder has had any position,
office or other material  relationship with the Company or any of its affiliates
during  the  past  three  years  (other  than  as  a  holder  of  the  Company's
securities), except that (i) Bert E. Brodsky has served as Chairman of the Board
and  Treasurer of the Company  since 1983 and  President  since 1989;  (ii) Hugh
Freund has served as a director of the  Company  since 1978 and  Executive  Vice
President of the Company  since 1986 (iii) Gary Stoller has served as a director
and Executive  Vice President of the Company since 1983; and (iv) B&B has been a
market maker of the Company's  Common Shares during such three year period.  B&B
acted as the placement  agent in a recent private  offering by the Company.  The
Company  believes that Messrs.  Steven R. Bronson,  James S. Cassel,  (and Mindy
Cassel),  Keil Stern, Eric R. Elliot,  Barry J. Booth, Bruce C. Barber, Barry E.
Steiner (and Ms. Lisa Steiner) and Scott Salpeter are affiliated with B&B.

                              PLAN OF DISTRIBUTION

     The Shares set forth in the "Selling Stockholders" table may be sold by the
Selling Stockholders, or by pledgees, donees, transferees or other successors in
interest, either pursuant to the Registration Statement of which this Prospectus
forms a part or, if available,  under Section 4(1) of the Securities Act or Rule
144 promulgated thereunder.

     To the Company's  knowledge,  this offering is not being underwritten.  The
Company  believes  that  the  Selling  Stockholders,   directly  through  agents
designated from time to time, or through  broker-dealers or underwriters also to
be designated  (who may purchase as principal and resell for their own account),
may sell the  Shares  from  time to time,  in or  through  privately  negotiated
transactions,  or in one or more transactions,  including block transactions, on
the NASDAQ SmallCap Market or on any other market or stock exchange on which the
Shares  may be listed  in the  future  pursuant  to and in  accordance  with the
applicable  rules of such market or exchange or otherwise.  The selling price of
the Shares may be at market  prices  prevailing  at the time of sale,  at prices
relating to such prevailing market prices or at negotiated prices.  From time to
time the Selling  Stockholders  may engage in short sales  against the box, puts
and calls and other  transactions  in securities  of the Company or  derivatives
thereof, and may sell and deliver the shares in connection  therewith.  Further,
except as set forth herein,  the Selling  Stockholders  are not restricted as to
the number of shares which may be sold at any one time,  and it is possible that
a significant  number of shares could be sold at the same time, which may have a
depressive effect on the market price of the Company's shares of Common Stock.

     The Selling  Stockholders  may also pledge shares as collateral  for margin
accounts,  and  such  shares  could  be  resold  pursuant  to the  terms of such
accounts.  Resales or reoffers of the Shares by the Selling Stockholders must be
accompanied by a copy of this Prospectus.


                                       19

<PAGE>



     The Selling  Stockholders  and any agents,  broker-dealers  or underwriters
that  participate  in  the  distribution  of the  Shares  may  be  deemed  to be
underwriters,  and  any  profit  on the  sale of the  Shares  by  them,  and any
discounts,  commissions  or  concessions  received by them,  may be deemed to be
underwriting commissions or discounts under the Securities Act.


                                  LEGAL MATTERS

     Matters relating to the legality of the securities being offered hereby are
being  passed upon for the  Company by  Certilman  Balin Adler & Hyman,  LLP, 90
Merrick Avenue, East Meadow, New York 11554.


                                     EXPERTS

     The consolidated  financial statements of the Company appearing in the Form
10-KSB,  as amended,  have been audited by Marcum & Kliegman,  LLP,  independent
auditors, as set forth in their report thereon included therein and incorporated
herein by reference.  Such  consolidated  financial  statements are incorporated
herein by  reference in reliance  upon such report  given upon the  authority of
such firm as experts in accounting and auditing.


                             ADDITIONAL INFORMATION

     The Company has filed a  Registration  Statement on Form S-3 (together with
all amendments thereto, the "Registration  Statement") with the Commission under
the Securities Act of 1933, as amended,  with respect to the securities  offered
hereby. This Prospectus does not contain all of the information set forth in the
Registration Statement.  For further information with respect to the Company and
the securities offered hereby,  reference is made to the Registration  Statement
and to the  exhibits  filed  therewith,  copies  of which may be  obtained  upon
payment of a fee prescribed by the Commission, or may be examined free of charge
at the public  reference  facilities  maintained by the  Commission at Judiciary
Plaza, 450 Fifth Street,  N.W.,  Washington,  D.C. 20549. Each statement made in
this Prospectus  referring to a document filed as an exhibit to the Registration
Statement is  qualified by reference to the exhibit for a complete  statement of
its terms and conditions.


                                       20

<PAGE>




                                     PART II

                     INFORMATION NOT REQUIRED IN PROSPECTUS

Item 14.  Other Expenses of Issuance and Distribution.


     The  following  table sets  forth the  expenses  (estimated  except for the
Registration Fee) in connection with the Offering  described in the Registration
Statement:

   
Registration Fee.......................................................$6,253.60
Accountants' Fees and Expenses..........................................3,000.00
Legal Fees and Expenses................................................17,000.00
Printing .............................................................. 1,500.00
Miscellaneous.............................................................500.00
Total.................................................................$28,253.66
    

Item 15.  Indemnification of Directors and Officers.

     Pursuant to Section 145 of the Delaware General  Corporation Law,  Sandata,
Inc. (hereinafter, the "Registrant") has the power, under certain circumstances,
to  indemnify  any  person who was or is a party or is  threatened  to be made a
party to any  threatened,  pending  or  completed  action,  suit or  proceeding,
whether civil, criminal,  administrative or investigative, by reason of the fact
that he is or was a director,  officer,  employee or agent of the Company, or is
or was serving at the request of the Company as a director, officer, employee or
agent  of  another  corporation,  partnership,  joint  venture,  trust  or other
enterprise against expenses (including  attorney's fees),  judgments,  fines and
amounts paid in settlement actually and reasonably incurred by him in connection
with such action, suit or proceeding.

     Article Tenth of the  Registrant's  Certificate of  Incorporation  provides
that the Registrant  shall, to the fullest extent permitted by said Section 145,
indemnify all persons whom it may indemnify pursuant thereto.

     Insofar as indemnification for liabilities arising under the Securities Act
of 1933 ("1933  Act") may be  permitted to  directors,  officers or  controlling
persons of the Registrant  pursuant to the foregoing  provisions,  or otherwise,
the  Registrant  has been advised that, in the opinion of the  Commission,  such
indemnification  is against  public  policy as expressed in the 1933 Act and is,
therefore, unenforceable. In the event that a claim for indemnification against
such liabilities  (other than the payment by the Registrant of expenses incurred
or paid by a director,  officer or  controlling  person of the Registrant in the
successful  defense of any  action,  suit or  proceeding)  is  asserted  by such
director,  officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been  settled by  controlling  precedent,  submit to a court of  appropriate
jurisdiction the question whether such  indemnification  by it is against public
policy  as  expressed  in the  1933  Act  and  will  be  governed  by the  final
adjudication of such issue.


                                      II-1

<PAGE>



Item 16.  Exhibits.

Exhibit Number      Description of Exhibit

   
 5                  Opinion of Certilman Balin Adler & Hyman, LLP regarding the 
                    legality of the securities being registered

10.1                Form of agreement between Sandsport and vendor agency*

10.2                Form of agreement between Sandsport and vendor agency**

10.3                Form of Subscription Agreement dated December 23, 1996*

10.4                Form of Subscription Agreement dated September 12, 1996*

10.5               Form of Common Stock Purchase Warrant ($5.00 Exercise Price)*
    

10.6                Form of Common Stock Purchase Warrant ($7.00 Exercise Price)

   
10.7                Form of Redeemable Common Stock Purchase Warrant*
    

23.1                Consent of Marcum & Kliegman, LLP

23.2                Consent of Certilman Balin Adler & Hyman, LLP (included in 
                    its opinion filed as Exhibit 5)

24                  Powers of Attorney (included in signature page forming a 
                    part hereof)




   
* Filed previously
**Supersedes prior filing
    


                                      II-2

<PAGE>




Item 17.  Undertakings.

     The undersigned Registrant hereby undertakes:

     (l) To file,  during any period in which  offers or sales are being made, a
post-effective amendment to this Registration Statement:

          (i) To include  any  prospectus  required  by Section  10(a)(3) of the
     Securities Act of 1933;

          (ii) To reflect in the  prospectus  any facts or events  arising after
     the  effective  date of the  Registration  Statement  (or the  most  recent
     post-effective amendment thereof) which,  individually or in the aggregate,
     represent  a  fundamental  change  in  the  information  set  forth  in the
     Registration  Statement;  notwithstanding  the  foregoing,  any increase or
     decrease in volume of securities  offered (if the total dollar value of the
     securities  offered  would not exceed  that which was  registered)  and any
     deviation from the low or high end of the estimated  maximum offering range
     may be  reflected  in the form of  prospectus  filed  with  the  Commission
     pursuant  to Rule  424(b) if, in the  aggregate,  the changes in volume and
     price  represent no more than a 20 percent change in the maximum  aggregate
     offering price set forth in the "Calculation of Registration  Fee" table in
     the effective Registration Statement; and

          (iii) To include any material  information with respect to the plan of
     distribution not previously disclosed in the Registration  Statement or any
     material  change  to  such  information  in  the  Registration   Statement;
     provided,  however,  that paragraphs (l)(i) and (l)(ii) do not apply if the
     Registration  Statement  is on Form S-3 or Form  S-8,  and the  information
     required to be included in a  post-effective  amendment by those paragraphs
     is  contained  in  periodic  reports  filed by the  registrant  pursuant to
     Section  13 or  15(d)  of the  Securities  Exchange  Act of 1934  that  are
     incorporated by reference in the Registration Statement.

     (2) That, for the purpose of determining any liability under the Securities
Act of 1933,  each  such  post-effective  amendment  shall be deemed to be a new
Registration  Statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

     (3) To remove from registration by means of a post- effective amendment any
of the securities being registered which remain unsold at the termination of the
offering.

     (4) That,  for purposes of determining  any liability  under the Securities
Act of 1933, as amended,  each filing of the Registrant's annual report pursuant
to  Section  13(a) or  15(d)  of the  Securities  Exchange  Act of 1934  that is
incorporated by reference in the Registration  Statement shall be deemed to be a
new Registration  Statement relating to the securities offered therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

     Insofar as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors,  officers and controlling  persons of the
Registrant  pursuant  to the  provisions  described  under  Item  15  above,  or
otherwise, the Registrant has been advised that in the opinion of the Securities
and Exchange Commission

                                      II-3

<PAGE>



   
     such   indemnification  is  against  public  policy  as  expressed  in  the
Securities Act and is, therefore,  unenforceable.  In the event that a claim for
indemnification  against  such  liabilities  (other  than  the  payment  by  the
Registrant of expenses  incurred or paid by a director,  officer or  controlling
person of the  Registrant  in the  successful  defense  of any  action,  suit or
proceeding)  is  asserted by such  director,  officer or  controlling  person in
connection with the securities being registered,  the Registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit  to a  court  of  appropriate  jurisdiction  the  question  whether  such
indemnification  by it is against  public policy as expressed in the  Securities
Act and will be governed by the final adjudication of such issue.
    

                                   SIGNATURES

   
     Pursuant to the  requirements of the Securities Act of 1933, the Registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-3 and has  duly  caused  this  Registration
Statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized,  in the City of Port Washington,  State of New York, on the 25th day
of April 1997.
    

                           SANDATA, INC.


                           By: /s/ Bert E. Brodsky
                           Bert E. Brodsky
                           President and
                           Chief Executive Officer




                                POWER OF ATTORNEY

     Know all men by these presents,  that each person whose  signature  appears
below  constitutes  and  appoints  Bert  E.  Brodsky  as  his  true  and  lawful
attorney-in-fact  and agent, with full power of substitution and  resubstitution
for him and in his name,  place and stead, in any and all capacities to sign any
and all amendments  (including  post-effective  amendments) to this Registration
Statement,  and to file the same, with all exhibits thereto, and other documents
in connection  therewith with the Securities and Exchange  Commission,  granting
unto said  attorney-in-fact and agent full power and authority to do and perform
each and every act and thing  requisite or necessary to be done in and about the
premises,  as  fully  to all  intents  and  purposes  as he might or could do in
person, hereby ratifying and confirming all that said attorney-in-fact and agent
or his substitute or substitutes,  may lawfully do or cause to be done by virtue
hereof.

     Pursuant  to  the   requirements  of  the  Securities  Act  of  1933,  this
Registration  Statement  has been signed below by the  following  persons in the
capacities and on the dates indicated.





                                      II-4

<PAGE>


Signature                      Capacity                       Date

   
                               President, Treasurer,
                               Chief Executive Officer
                               and Chairman of the
                               Board (Principal
                               Executive Officer and
                               Principal Financial and
/s/ Bert E. Brodsky            Accounting Officer)             April 25, 1997
- ---------------------
Bert E. Brodsky

                               Executive Vice President
                               Secretary
/s/Hugh Freund                 and Director                    April 25, 1997
- ----------------------
Hugh Freund

                               Executive Vice President
/s/ Gary Stoller               and Director                    April 25, 1997
- ---------------------
Gary Stoller
    


                                      II-5

<PAGE>









                                 April 25, 1997


Sandata, Inc.
26 Harbor Park Drive
Port Washington, New York  11050

     Re: Sandata, Inc./Amendment No. 2 to Registration Statement on Form S-3

Gentlemen:

     In our capacity as counsel to Sandata,  Inc., a Delaware  corporation  (the
"Company"),  we have been asked to render this  opinion in  connection  with the
Company's  Registration  Statement  on Form S-3 (the  "Registration  Statement")
being filed  contemporaneously  by the Company with the  Securities and Exchange
Commission  under the  Securities  Act of 1933, as amended,  covering  1,988,140
shares of Common  Stock,  $.001 par value,  of the Company  which are either (i)
issuable by the Company to certain  persons and  entities  upon the  exercise of
certain  options and warrants (the "Issuable  Shares") and are being  registered
for  resale  by  such  persons  and  entities;  or (ii)  shares  of  issued  and
outstanding  Common  Stock,  $.001  par  value,  of the  Company  (the  "Selling
Stockholder  Shares")  which are owned by certain  persons and  entities and are
being  registered for resale by such persons and entities.  The Issuable  Shares
and the Selling  Stockholder  Shares are collectively  referred to herein as the
"Shares".

     In  connection  with our  opinion,  we have  examined  the  Certificate  of
Incorporation  and By-Laws of the  Company,  each as amended,  the  Registration
Statement,  and certain  agreements  entered into, and  instruments and warrants
issued,  by the Company in  connection  with the issuance of the Shares.  We are
also  familiar  with  proceedings  of the Board of Directors of the Company,  or
otherwise  have relied  upon  representations  made by officers of the  Company,
relating  to the  authorization  of the  issuance  of the  Shares.  We have also
examined such other  instruments  and documents as we deemed  relevant under the
circumstances.

     For  purposes of the  opinions  expressed  below,  we have  assumed (i) the
authenticity of all documents submitted to us as originals,  (ii) the conformity
to the  originals  of all  documents  submitted  as  certified,  photostatic  or
facsimile copies and the authenticity of the originals, (iii) the legal capacity
of natural persons,  (iv) the due  authorization,  execution and delivery of all
documents by all parties and the validity and binding effect thereof and (v) the
conformity to the  proceedings  of the Board of Directors of all minutes of such
proceedings and all representations, oral and


<PAGE>


Sandata, Inc.
April 25, 1997
Page 2

written,  made by officers of the Company  with  respect  thereto.  We have also
assumed that the corporate  records  furnished to us by the Company  include all
corporate proceedings taken by the Company to date.

     Based upon and subject to the foregoing  including the assumptions made, we
are of the opinion that (i) the Selling Stockholder Shares were duly and validly
authorized  and  issued and are fully  paid and  nonassessable  shares of Common
Stock,  $.001 par value,  of the Company,  and (ii) the Issuable Shares will be,
upon  issuance  in  accordance  with the  terms of the  respective  options  and
warrants,  duly and validly authorized and issued,  fully paid and nonassessable
shares of Common Stock, .$001 par value, of the Company.

     We hereby  consent  to the use of our  opinion  as  herein  set forth as an
exhibit  to the  Registration  Statement  and to the use of our name  under  the
caption  "Legal  Matters" in the Prospectus  forming a part of the  Registration
Statement.

     This opinion is as of the date hereof, and we do not undertake,  and hereby
disclaim,  any obligation to advise you of any changes in any of the matters set
forth herein.

     We are  rendering  this opinion only as to the matters  expressly set forth
herein, and no opinion should be inferred as to any other matters.

     This  opinion  is for your  exclusive  use only and is to be  utilized  and
relied upon only in connection with the matters expressly set forth herein.


                                Very truly yours,
                                
                                /s/ CERTILMAN BALIN ADLER & HYMAN, LLP

                                CERTILMAN BALIN ADLER & HYMAN, LLP


<PAGE>



                                SanTrax Contract

     Agreement,  made this day of 1995 between Sandsport Data Services,  Inc., a
domestic  corporation  having its  principal  place of office at 26 Harbor  Park
Drive,  Port Washington,  New York,  hereinafter  referred to as "Processor" and
__________________________________.,   a  domestic  not-for-profit   corporation
having its principal office at __________________________, herein referred to as
"Vendor".

     Whereas,  Vendor is in the business of rendering home care services  within
the jurisdiction of the Human Resources  Administration of the City of New York,
hereinafter  referred to as "HRA", and under contract by the City of New York to
render  services  to City's  clients and Vendor  desires  certain  computer  and
telephone-related  services as provided herein; and whereas,  processor desires,
and is able, to furnish such services as provided herein.

     Now, therefore,  in consideration of the mutual agreements set forth herein
the parties hereto agree as follows:

     1. Vendor  represents to Processor that it has contracted  with the City of
New York, to deliver home attendant services to designated clients.

     2. Vendor will make available to Processor client schedules, client's phone
numbers,  and  client's  name.  Vendor  will also make  available  to  Processor
attendant's name and social security number.

     3.  Processor  will  assign  to  Vendor  an 800  telephone  number to allow
attendant  to log in and log out  from  client's  residence  when  arriving  and
departing.

     4. Client authorized  twenty-four hour assignment  (sleep-in  cases),  will
require attendant to log in once a day at an assigned time.

     5. Cluster client cases,  will require attendant to log in at the beginning
of each assignment and log out at the end of the day from last assignment.

     6. The Vendor will be responsible  for  maintaining  the client database of
information including client schedule and client phone number, and the attendant
database of information  including  attendant's name and social security number.
The On-Line Time Sheet System (OTS) provides  Vendor with the facility to update
the client (including the schedule) and the attendant data base.

     7.  Processor  will  record all calls  received.  SanTrax  will  verify the
following:

         -        Call was received from correct client location.
         -        The attendant social security number is from an active 
                  employee of the Vendor.
         -        Calls received were for scheduled assigned times.

     8. SanTrax will generate reports on demand as follows:


<PAGE>



         -        No show report - listing all clients scheduled to receive care
                  and no call was received from home care worker.
         -        Unscheduled report - listing of clients who are not scheduled 
                  to receive care yet a log in call was received.
         -        Unidentified  phone numbers - listing of phone calls  received
                  that are not identified as belonging to any clients.
         -        Unidentified attendants - listing of unidentifiable employee 
                  social security numbers that were received.
         -        Daily call summary - listing of all activity from the 
                  preceding day.
         -        Weekly call summary - listing of all activity from preceding 
                  week.

     9. SanTrax  will  consider an  attendant  on-time if they arrive  within __
minutes of their  assigned time. The attendant will also be given full credit if
they leave within __ minutes of the scheduled depart time.  However,  at the end
of the week,  the system will  accumulate  all the late minutes and reduce total
hours  worked  in  increments  of __  minutes.  The most the  attendant  will be
credited  within one week for time not worked is __  minutes.  The  rounding  of
hours will be performed within each client assigned that week.

     10. The Vendor will  require  attendants  to log in when they arrive at the
assigned  client's home by picking up the phone and  depressing the tones on the
phone to correspond to employee's  social security  number,  or the employee can
enter his or her social security  number by speaking the digits into phone.  The
attendant will log out when leaving the assigned  client's  home,  following the
same  procedure as the log in. The maximum calls per visit should not exceed two
calls.

     11. As an option,  SanTrax can verify the person  calling is the individual
assigned.  The feature is voice  verification  and requires  caller to use voice
recognition.  To use the feature,  all  employees  must go through an enrollment
process.

     12.  The log in and  log out  times  cannot  be  altered;  they  remain  as
permanent  records.  The Vendor may adjust  total hours  worked  when  situation
warrants. Special passwords are available to limit access to this feature.

     13. The Processor will tally hours worked daily. The Vendor will review the
Daily Call Summary and make adjustments and corrections. The hours recorded will
be inputted into the payroll module and the MMIS billing module.

     14.  Processor  agrees that all information  pertaining to the recipient or
the provider of services  contained in its files and all information  pertaining
to such  recipients  and/or  providers  or learned  from  official  HRA files or
records or from other sources,  shall be held confidential by processor pursuant
to the provisions of the New York State Social  Services Law, the Federal Social
Security  Act and any  other  applicable  laws  and any  regulation  promulgated
thereunder, and shall not be disclosed to unauthorized persons.

     15. Processor agrees not to use, for any unauthorized  purpose  whatsoever,
any  information  pertaining to the recipient or provider of services or learned
from Vendor or official HRA


<PAGE>



     files or records,  or from other  sources.  For the purpose of this clause,
unauthorized  purpose means any use  whatsoever not  specifically  authorized by
Vendor.

     16. In the event that the  contract  between the Vendor and the City of New
York is terminated for any reason whatsoever,  or the City of New York dissolves
the program involved herein, this contract shall terminate immediately.

     17. The terms of this Agreement shall run through  ______________ and shall
continue  thereafter  until terminated by either party on at least __ days prior
written notice to the other.  Sandsport  agrees that it will not increase any of
the fees  through  _______________.  Thereafter  such fees may be  increased  by
Sandsport upon at least __ days prior written  notice to Vendor.  Any such price
increase shall become  effective  unless Vendor gives Sandsport at least __ days
prior  written  notice of its  intention  to  terminate  this  Agreement  on the
effective  date of such  increase,  in which  case  this  Agreement  shall,  not
withstanding anything to the contrary, terminate on such date.

     18. This contract  embodies all the terms of the agreement between parties.
Any modifications hereto shall be in writing and signed by both parties.

     19. Any disputes  arising between the parties as to billing charges must be
settled within ______ of receipt of billing by Vendor.

     20.  Processor  agrees  to  allow  audit  firms  hired  by  Human  Resource
Administration  of the City of New  York,  to audit  its  computer  systems  and
operating  procedures  in order to form an opinion of the security and integrity
of the system.

     21.  Vendor  hereby  acknowledges  that it shall have access to and come in
contact  with certain  information  and  documentation  which is the property of
Processor which is copyrighted  and/or which  Processor  considers a proprietary
trade secret ("Confidential Information"). Vendor hereby agrees that:

         -        All such  confidential  information  shall be  retained at the
                  premises of Vendor unless Vendor obtains the expressed written
                  consent of the Processor  that such  confidential  information
                  may be removed.
         -        Vendor will use  reasonable  means (not less than that used to
                  protect  its  own   proprietary   information)   to  safeguard
                  Processor's confidential information.
         -        Vendor shall not show or otherwise disclose any portion of the
                  materials   or  their   contents  to  anyone  other  than  its
                  employees.
         -        It will make no copies of the confidential information.
         -        It will return all confidential information promptly upon 
                  request of the company.

     22. Processor agrees to comply with equal employment  provision relating to
subcontractors,  where applicable,  that are set forth in Part II, Section 6, of
the Home Attendant  Service  Agreement between Vendor and HRA and all amendments
and modifications to such provisions.



<PAGE>



     23.  Processor  will not violate or in any way infringe  upon the rights of
third parties, including, but not limited to, property, contractual, employment,
trade  secrets,   proprietary  information  and  nondisclosure  rights,  or  any
trademark, copyright or patent rights.

     24.  Processor  is the lawful user of all programs  used in  providing  the
services  hereunder;  rights to use such programs have been lawfully acquired by
Processor and Processor has the absolute right to permit Vendor access to or use
such programs.

     25.  Processor  will comply with and be  responsible  for ensuring that its
employees,  agents and subcontractors comply with all applicable federal, state,
and local  laws,  rules,  and  regulations  relating to the  performance  of the
services,  and that it will have obtained such permits licenses, and other forms
of documentation and authorization  required to comply with such laws, rules and
regulations.

     26. Processor hereby indemnifies and shall hold harmless Vendor against all
liability  to third  parties  (other  than  liability  which is the fault of the
Vendor), including,  without limitation, (a) any liability incurred (but only as
the  result  of a  final,  binding  and  non-appealable  judgment  of a court of
competent  jurisdiction)  directly based upon Processor's actual infringement of
U.S.  Patent Number  5,255,183 and (b) any liability  incurred as a result of an
improper  determination  of benefit  eligibility,  arising from or in connection
with  Processor's  improper  performance  of the  services  or any breach of the
Processor's  warranties  provided  for  herein and  accordingly  shall on demand
reimburse any indemnified party for any and all loss. Liability,  fine, penalty,
cost, or expense which may for any reason be imposed upon any indemnified  party
by reason of any suit,  claim,  action,  proceeding or demand by and third party
which results from Processor's performance of the services.

     27. This Agreement  shall be governed by the laws of the State of New York,
without  regard to principles  of conflict of laws but including any  applicable
provisions of the New York Uniform  Commercial  Code,  except to the extent that
the provisions of this Agreement are clearly  inconsistent  therewith,  in which
case the provisions hereof shall be controlling.

     28. Any notices or other  communications  required or  permitted  hereunder
shall be in writing and will be deemed  sufficiently  given only if delivered in
person or sent by telex,  telecopier,  first-class  mail or  recognized  courier
service, postage and other charges pre-paid addressed as follows:

         If to Processor:

         Sandata SanTrax
         Sandsport Data Services
         26 Harbor Park Drive
         Port Washington, NY 11050

         Attention:  President

         If to Vendor:


<PAGE>


         Address of Vendor

         Attention:  Director (or to such other address as the addressee may 
         have specified in a notice duly given to the sender as provided herein.

     29. Vendor agrees to pay Processor as follows:

                  Start up fee      $

                  Weekly per client charge
                               (or)
                  Optional:  Voice verification:
                  Enrollment fee per attendant
                  Weekly per client charge

     30. This  Agreement,  together  with any  schedules,  appendices  and other
attachments hereto, all of which are hereby incorporated by reference herein and
made  a part  of  this  Agreement,  constitutes  the  entire  Agreement  between
Processor  and Vendor and  supersedes  all  proposals,  oral and written and all
other  communications  between the parties in relation to the subject  matter of
this Agreement. Except as otherwise provided herein, no amendment,  modification
or other variation of this Agreement shall be effective until reduced to writing
and executed by the parties hereto.

     In witness  whereof,  the parties have caused this Agreement to be executed
by their respective duly authorized officers.

SANDSPORT DATA SERVICES, INC.                    VENDOR


- ----------------------------------               --------------------------
Hugh Freund                                       Name
President                                         Title


- ---------------------------------                --------------------------
Date                                              Date


<PAGE>




         VOID AFTER 5:00 P.M., MIAMI, FLORIDA TIME, ON DECEMBER 22, 2001.

         NEITHER THIS WARRANT NOR THE SHARES ISSUABLE UPON THE EXERCISE  THEREOF
HAVE BEEN  REGISTERED  UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"),
OR THE SECURITIES LAWS OF ANY STATE.

         THE WARRANT  REPRESENTED BY THIS  CERTIFICATE  AND THE SHARES  ISSUABLE
UPON  EXERCISE  THEREOF  MAY NOT BE  SOLD,  TRANSFERRED,  ASSIGNED,  PLEDGED  OR
OTHERWISE DISPOSED OF, IN WHOLE OR IN PART (COLLECTIVELY, A "TRANSFER"),  UNLESS
ANY  SUCH  TRANSFER  IS  REGISTERED  UNDER  THE  ACT AND  ANY  APPLICABLE  STATE
SECURITIES LAWS, OR AN EXEMPTION FROM THE REGISTRATION  REQUIREMENTS  UNDER SAID
ACT IS  AVAILABLE,  AND THE COMPANY  HAS  RECEIVED AN OPINION OF COUNSEL TO SUCH
EFFECT,  WHICH OPINION IS REASONABLY  SATISFACTORY  TO THE COMPANY.  THIS LEGEND
SHALL BE ENDORSED ON ANY WARRANT ISSUED IN EXCHANGE FOR THIS WARRANT.

                                  SANDATA, INC.

                    REDEEMABLE COMMON STOCK PURCHASE WARRANT

                           Warrant Certificate No. 1~

     1. Number and Price of Shares of Common  Stock  Subject to Common Stock
Purchase Warrant.  Subject to the terms and conditions hereinafter set forth, 2~
(the  "Holder"),  is  entitled  to  purchase  from  Sandata,  Inc.,  a  Delaware
corporation (the "Company"), at any time and from time to time during the period
from December 23, 1996 (the "Commencement Date") until 5:00 p.m., Miami, Florida
Time,  on  December  22,  2001  (the  "Expiration  Date"),  at which  time  this
Redeemable Common Stock Purchase Warrant (the "Warrant") shall expire and become
void, an aggregate of 3~ shares (the "Warrant  Shares") of the Company's  common
stock,  $.001 par value per share (the "Common Stock"),  which number of Warrant
Shares is subject to  adjustment  from time to time,  as described  below,  upon
payment  therefor of the exercise  price of $7.00 per Warrant  Share,  in lawful
funds of the United States of America, such amounts (the "Basic Exercise Price")
being subject to adjustment in the  circumstances  set forth  hereinbelow.  This
applicable Basic Exercise Price, until such adjustment is made and thereafter as
adjusted from time to time, is called the "Exercise Price."

     2. Exercise of Warrant.  This  Warrant may be exercised in whole or in
part at any time  from and  after the  Commencement  Date and on or  before  the
Expiration  Date,  provided  however,  if such Expiration Date is a day on which
Federal or State chartered banking  institutions located in the State of Florida
are authorized by law to close,  then the Expiration  Date shall be deemed to be
the next  succeeding  day which  shall not be such a day,  by  presentation  and
surrender  to the  Company  at its  principal  office,  or at the  office of any
transfer agent for the Warrants ("Transfer  Agent"),  designated by the Company,
of this Warrant

CORP\02437\0068\LCFJLS12.21A
970408
                                       -1-

<PAGE>



accompanied  by the form of election to purchase on the last page hereof  signed
by the Holder and upon  payment of the  Exercise  Price for the  Warrant  Shares
purchased  thereby,  by  cashier's  check  or by wire  transfer  of  immediately
available  funds.  If this  Warrant is  exercised  in part only,  the Company or
Transfer  Agent shall,  promptly  after  presentation  of this Warrant upon such
exercise,  execute and deliver a new Warrant, dated the date hereof,  evidencing
the  rights  of the  Holder  to  purchase  the  balance  of the  Warrant  Shares
purchasable  hereunder upon the same terms and conditions herein set forth. This
Warrant shall be deemed to have been exercised immediately prior to the close of
business on the date of its  surrender for exercise as provided  above,  and the
person entitled to receive the Warrant Shares or other securities  issuable upon
such exercise  shall be treated for all purposes as the holder of such shares of
record as of the close of business on such date. As promptly as practicable, the
Company shall issue and deliver to the person or persons entitled to receive the
same a  certificate  or  certificates  for the  number  of full  Warrant  Shares
issuable  upon such  exercise,  together  with cash in lieu of any fraction of a
share as provided below.

     3. Call Option.

        At any time prior to the expiration of this Warrant, except as
provided below, the Company shall have the right and option,  upon notice mailed
to the  Holder,  to call,  redeem  and  acquire  all of the  Warrants  remaining
outstanding  and  unexercised  at the date  fixed  for such  redemption  in such
notice,  which  redemption date shall be at least 30 days after the date of such
notice,  for an  amount  equal to $.01 per  underlying  share  (the  "Redemption
Price");  provided, that the Company may exercise such right and option only if,
for 20  consecutive  trading  days ending  within 10 calendar  days prior to the
redemption  notice date,  the closing price per share of the Common Stock equals
or  exceeds  $9.00,  such  amount  being  subject to  adjustment  under the same
circumstances and in the same proportion as the Exercise Price. The Holder shall
have the right, during the 20-day period immediately  following the date of such
notice,  to exercise the  Warrants.  If any Warrants are  exercised  during such
20-day  period,  this call option shall be deemed not to have been  exercised by
the Company as to the Warrant Shares so exercised by the Holder.  Said notice of
redemption  shall  require the Holder to surrender to the Company,  on or before
the redemption  date, at the offices of the Company,  or its warrant  agent,  if
any, the certificate or certificates  representing  the Warrants to be redeemed.
Notwithstanding  the fact that any Warrants  called for redemption have not been
surrendered for redemption and  cancellation on the redemption  date,  after the
redemption  date,  such Warrants shall be deemed to be expired and all rights of
the  Holder  with  respect  to  such  unsurrendered  Warrants  shall  cease  and
terminate,  other than the right to receive the Redemption  Price. The rights of
the Company  pursuant to this Section 3 are conditioned upon the registration by
the  Company of the resale of the Warrant  Shares  under the  Securities  Act of
1933, as amended (the "Securities  Act"),  pursuant to a registration  statement
which is kept  current by the  Company for at least 120 days after the notice of
redemption.


CORP\02437\0068\LCFJLS12.21A
970408
                                       -2-

<PAGE>



     4. Registration Rights.

        4.1 The Company will, as soon as reasonably possible following
issuance of these  Warrants,  file a registration  statement with the Securities
and Exchange  Commission (the  "Commission")  for the purpose of registering the
re-sale by the Holders thereof of the Common Stock issuable upon exercise of the
Warrant.

        4.2 In addition, if, at any time prior to the Expiration Date,
the  Holders of a  majority  of the  Warrants  Shares  shall give  notice to the
Company  requesting  that the  Company  file with the  Securities  and  Exchange
Commission  (the  "Commission")  a  registration  statement  (the  "Registration
Statement")  relating  to the offer and  re-sale  of the  Warrant  Shares by the
Holder,  the  Company  shall  promptly  give  written  notice  of such  proposed
Registration Statement to the Holders of such Warrants or Warrant Shares, and to
any subsequent  permissible  transferee of any of the Warrants or Warrant Shares
(at the  address of such  persons  appearing  on the books of the Company or its
transfer  agent) which  notice shall offer to include the Warrant  Shares in the
requested  Registration  Statement.  The  Company  shall,  as  expeditiously  as
possible, file and use its reasonable efforts to cause to become effective under
the Securities Act, the Registration  Statement covering the sale of such of the
Warrant Shares by such Holders as the Company has been requested to register for
disposition by the Holders thereof,  to the extent required to permit the public
sale or other public disposition thereof by the Holders. The Company shall cause
the Registration Statement to remain effective for a period of at least 120 days
from the effective  date of the  Registration  Statement or such earlier date as
all of the Warrant Shares have been sold or the Warrants  expire (the "Effective
Period"). The Holders shall have the right to demand registration of the Warrant
Shares  as  described  above  on one  occasion  only.  Notwithstanding  anything
contained herein to the contrary, the Holders may not demand registration of the
Warrant Shares if the Warrant Shares may otherwise be sold without  registration
under the Securities Act or applicable state securities laws and regulations and
without  limitation  as to volume  pursuant to Rule 144 of the  Securities  Act.
Notwithstanding anything contained herein, the Company shall not be obligated to
file or use its reasonable  efforts to cause to become  effective a registration
statement  under this  section  during any period  commencing  with the date the
Company files a registration statement relating to the sale or exchange by it of
its securities in either an underwritten  offering or in an offering involving a
merger, acquisition, combination or reorganization and ending with the date such
registration statement becomes effective.

        4.3 In addition,  if at any time prior to the Expiration Date,
the Company shall prepare and file one or more registration statements under the
Securities Act (other than a registration  statement on Form S-4 (or with regard
to any transaction  contemplated  by Rule 145  promulgated  under the Securities
Act) or Form S-8 or any  successor  form of  limited  purpose  and other  than a
post-effective  amendment  to any such  registration  statement),  to the extent
permitted by law, including,  without  limitation,  the rules and regulations of
the  Commission,  with respect to a public offering of equity or debt securities
of the Company,  or of any such  securities  of the Company held by its security
holders,  the  Company  will  include in any such  registration  statement  such
information as is required, and such number of Warrant Shares held by the

CORP\02437\0068\LCFJLS12.21A
970408
                                       -3-

<PAGE>



Holders thereof or their respective designees or transferees as may be requested
by them,  to  permit a public  offering  of the  Warrant  Shares  so  requested;
provided,  however,  that if, in the written  opinion of the Company's  managing
underwriter,  if any, for such  offering,  the  inclusion of the Warrant  Shares
requested to be registered, when added to the securities being registered by the
Company or the selling  security  holder(s),  would exceed the maximum amount of
the Company's  securities that can be marketed without otherwise  materially and
adversely affecting the entire offering,  then the Company may exclude from such
offering  all  or  that  portion  of  the  Warrant  Shares  requested  to  be so
registered,  so that the total number of  securities  to be registered is within
the maximum  number of shares that, in the opinion of the managing  underwriter,
may be marketed without otherwise  materially and adversely affecting the entire
offering,  provided  that at  least a pro rata  amount  of the  securities  that
otherwise  were  proposed  to be  registered  for  other  stockholders  is  also
excluded.  In the  event  of  such  a  proposed  registration  (other  than  the
registration  statement  contemplated  by Section 4.1 above),  the Company shall
furnish the then Holders of Warrant  Shares with not less than 20 days'  written
notice  prior to the  proposed  date of filing of such  registration  statement.
Further notice shall be given by the Company to Holders of Warrant Shares,  with
respect to subsequent registration statements or post-effective amendments filed
by  the  Company,  until  such  time  as all of the  Warrant  Shares  have  been
registered  or may be sold  without  registration  under the  Securities  Act or
applicable  state  securities laws and  regulations  pursuant to Rule 144 of the
Securities Act. The holders of Warrant Shares shall exercise the rights provided
for in this Section 4.3 by giving written notice to the Company, within ten days
of receipt  of the  Company's  notice of its  intention  to file a  registration
statement.  Notwithstanding  anything  contained  herein  to the  contrary,  the
Company may delay the effectiveness of such  registration  statement or withdraw
such registration  statement;  provided,  however,  the Company must provide the
Holders of Warrant Shares with notice of such delay or withdrawal.

        4.4 Notwithstanding anything contained herein to the contrary,
the Holders shall not be permitted to exercise the registration  rights provided
for herein with respect to all or such  portion of the Warrant  Shares as may be
sold  without   registration  under  the  Securities  Act  or  applicable  state
securities laws and regulations under Rule 144 of the Securities Act.

        4.5 The  Company  shall  bear all  expenses,  incurred  in the
preparation  and  filing  of  such  registration  statements  or  post-effective
amendment  (and  related  state  registrations,   to  the  extent  permitted  by
applicable  law) and the  furnishing  of  copies  of the  preliminary  and final
prospectus  thereof to the Holder,  other than expenses of the Holder's counsel,
and other than sales  commissions or transfer taxes incurred by the then holders
with respect to the sale of such securities.

        4.6  Notwithstanding  the  foregoing,  if  the  Company  shall
furnish to Holders  requesting a registration  statement pursuant to Section 4.2
or  Section  4.3, a  certificate  signed by the Chief  Executive  Officer of the
Company stating that in the good faith judgment of the Board of Directors of the
Company,  it would be seriously  detrimental to the Company and its stockholders
for such registration  statement to be filed or go effective and it is therefore
essential to defer the filing or effectiveness of such  registration  statement,
then the Company shall have

CORP\02437\0068\LCFJLS12.21A
970408
                                       -4-

<PAGE>



the right to defer taking  action with  respect to such filing or  effectiveness
for a period  of not more  than 90 days  after  receipt  of the  request  of the
Holders;  provided,  however,  that the Company may not utilize  this right more
than once in any twelve-month period.

        4.7 Notwithstanding the provisions of Sections 4.2 and 4.3, if
at any time during which the Company is obligated to maintain the  effectiveness
of a  registration  statement  pursuant to such Section,  counsel to the Company
(which  counsel shall be  experienced  in securities  matters) has determined in
good faith that the filing of such  registration  statement or the compliance by
the  Company  with its  disclosure  obligations  thereunder  would  require  the
disclosure  of material  information  which the Company has a bona fide business
purpose for preserving as confidential, then the Company may delay the filing or
the  effectiveness  of  such  registration  statement  (if  not  then  filed  or
effective,   as  appropriate)   and  shall  not  be  required  to  maintain  the
effectiveness  thereof (if previously  declared effective) for a period expiring
upon the earlier to occur of (i) the date on which such information is disclosed
to the public or ceases to be  material or the Company is so able to comply with
its disclosure  obligations,  or (ii) 30 days after counsel to the Company makes
such good  faith  determination.  There  shall  not be more than one such  delay
period with respect to any  registration  statement  after it has been  declared
effective  pursuant to Sections 4.2 and 4.3. Notice of any such delay period and
of the  termination  thereof  will be promptly  delivered by the Company to each
Holder and shall be maintained  in  confidence by each such Holder.  The Holders
shall not sell any Warrant  Shares  during such period as any such  registration
statement is not current,  as advised by the Company.  Each Holder shall furnish
to the Company such information  regarding such Holder and a written description
of the  contribution  proposed  by such  Holder as the  Company  may  reasonably
request.

        4.8  Each  Holder  whose  Warrant  Shares  are  included  in a
registration  statement  pursuant to an  underwritten  public offering shall, if
requested  by the managing  underwriter  of the public  offering,  enter into an
agreement  with the  underwriter  pursuant to which the Holder will agree not to
sell,  Transfer or otherwise dispose of the Warrant Shares for such period after
consummation  of the public  offering  as may  reasonably  be  requested  by the
underwriter, up to a maximum of 90 days, without the consent of the underwriter.

     5. Reservation of Common Stock. The Company  covenants that, during the
period this Warrant is exercisable, the Company will reserve from its authorized
and  unissued  Common  Stock a  sufficient  number of shares of Common  Stock to
provide  for the  issuance  of the  Warrant  Shares  upon the  exercise  of this
Warrant.  This Company agrees that its issuance of this Warrant shall constitute
full authority to its officers who are charged with the duty of executing  stock
certificates to execute and issue the necessary  certificates for Warrant Shares
upon the exercise of this Warrant.

     6. No Stockholder Rights.  This Warrant, as such, shall not entitle the 
Holder to any rights of a stockholder of the Company, until the Holder has 
exercised this Warrant in accordance with Section 2 hereof.


CORP\02437\0068\LCFJLS12.21A
970408
                                       -5-

<PAGE>



     7. Adjustment of Exercise Price and Number of Warrant Shares.

        7.1 The  number  and  kind of  securities  issuable  upon  the
exercise of this Warrant shall be subject to adjustment  from time to time,  and
the Company  agrees to provide notice upon the happening of certain  events,  as
follows:

            a. If the Company is recapitalized through the subdivision or
combination of its  outstanding  shares of Common Stock into a larger or smaller
number of shares of Common Stock, the number of shares of Common Stock for which
this  Warrant may be exercised  shall be increased or reduced,  as of the record
date for  such  recapitalization,  in the same  proportion  as the  increase  or
decrease in the outstanding shares of Common Stock, and the Exercise Price shall
be adjusted so that the aggregate  amount payable for the purchase of all of the
Warrant Shares  issuable  hereunder  immediately  after the record date for such
recapitalization  shall equal the aggregate amount so payable immediately before
such record date.

            b. If the Company declares a dividend on its Common Stock payable
in shares of its  Common  Stock or  securities  convertible  into  shares of its
Common Stock, the number of shares of Common Stock for which this Warrant may be
exercised shall be increased as of the record date for determining which holders
of Common Stock shall be entitled to receive such dividend, in proportion to the
increase  in the number of  outstanding  shares of Common  Stock (and  shares of
Common Stock issuable upon  conversion of all such securities  convertible  into
shares of Common  Stock) as a result of such  dividend,  and the Exercise  Price
shall be adjusted so that the aggregate  amount  payable for the purchase of all
the Warrant Shares issuable hereunder immediately after the record date for such
dividend  shall equal the aggregate  amount so payable  immediately  before such
record date.

            c.  If the Company effects a general distribution to holders of its
Common Stock, other than as part of the Company's  dissolution or liquidation or
the winding up of its affairs,  of any shares of its capital stock, any evidence
of indebtedness or any of its assets (other than cash, shares of Common Stock or
securities  convertible  into shares of Common  Stock),  the Company  shall give
written notice to the Holder of any such general  distribution  at least 15 days
prior to the proposed record date in order to permit the Holder to exercise this
Warrant on or before the record date. There shall be no adjustment in the number
of shares of Common  Stock for which this  Warrant may be  exercised,  or in the
Exercise Price, by virtue of any such general distribution,  except as otherwise
provided herein.

            d. If the Company offers rights or warrants (other than the Warrant)
to all  holders  of its Common  Stock  which  entitle  them to  subscribe  to or
purchase additional shares of Common Stock or securities convertible into shares
of Common  Stock,  the Company  shall give written  notice of any such  proposed
offering  to the Holder at least 15 days prior to the  proposed  record  date in
order to permit the Holder to  exercise  this  Warrant on or before  such record
date.


CORP\02437\0068\LCFJLS12.21A
970408
                                       -6-

<PAGE>



           e. In the event an adjustment in the Exercise Price or the number of
Warrant Shares issuable  hereunder is made under  subsection a. or b. above, and
such an event does not occur,  then any  adjustments  in the  Exercise  Price or
number of Warrant  Shares  issuable upon exercise of this Warrant that were made
in accordance with such subsection a. or b. shall be re-adjusted to the Exercise
Price and number of Warrant  Shares as were in effect  immediately  prior to the
record date for such an event.

           f. If and whenever the Company issues or sells, or in accordance with
Section 7.1 is deemed to have issued or sold, any shares of its Common Stock for
a  consideration  per share less than the Exercise  Price in effect  immediately
prior to the time of such  issuance  or sale  (except  for the  issuance  of the
Common  Stock  Purchase   Warrants  to  B  C  Capital  Corp.  or  its  designees
simultaneously  herewith or the issuance or deemed  issuance of  securities in a
transaction  described in paragraph g. of this Section  7.1),  then  immediately
upon such  issuance  or sale the  Exercise  Price will be reduced to an Exercise
Price determined by multiplying the Exercise Price in effect  immediately  prior
to the issuance or sale by a fraction,  the  numerator of which shall be the sum
of (i) the number of shares of Common Stock outstanding prior to the issuance or
sale plus (ii) the number of Warrant Shares issuable  hereunder that the maximum
aggregate amount of  consideration  receivable by the Company upon such issuance
or sale would purchase at the Exercise Price in effect  immediately prior to the
issuance or sale, and the  denominator of which shall be the number of shares of
Common Stock deemed outstanding,  as hereinafter  determined,  immediately after
such issuance or sale.

            g. Notwithstanding anything contained herein to the contrary, the
following securities or transactions shall be excluded from the operation of 
paragraph f. of this Section 7.1:

               (i)   The existence and any exercise, conversion and/or exchange
of  any  option,   convertible  promissory  note  and/or  other  convertible  or
exchangeable security, warrant, or other right to purchase Common Stock, that is
outstanding  on  the  date  hereof   (whether  or  not  currently   exercisable,
convertible or exchangeable); and

               (ii)   Any grant or exercise of options for Common Stock granted
under the  Company's  stock  option  plans,  in existence as of the date hereof,
provided said grant or exercise is not  effectuated as a result of any amendment
to such plans subsequent to the date hereof,  with an exercise price equal to at
least the fair market  value of the shares of Common Stock on the date of grant.
Notwithstanding anything contained herein to the contrary, if the Company amends
such plans  with the  consent of Barber & Bronson  Incorporated  (which  consent
shall not be unreasonably  withheld or delayed),  the securities issued pursuant
to such plan,  as amended,  shall be excluded from the operation of paragraph f.
of this Section 7.1. As used herein, the term "fair market value" shall mean the
closing bid price, or, if not available, the highest bid price, of the shares of
Common  Stock  as  quoted  on  a  national  securities   exchange,   or  in  the
over-the-counter  market as  reported  by Nasdaq  or, if not  available,  by the
National Quotation Bureau, Incorporated,  as the case may be (or, if there is no
bid price on a particular  day, then the closing bid price or, if not available,
the highest bid price on the nearest trading

CORP\02437\0068\LCFJLS12.21A
970408
                                       -7-

<PAGE>



date before that day and for which such prices are available), and if the shares
of Common Stock are not listed on such an exchange or traded in such a market on
such particular day, then the fair market value per share shall be determined by
mutual  agreement  of the Board of  Directors  and the  Holders  by taking  into
consideration all relevant factors, including, but not limited to, the Company's
net worth, prospective earning power and dividend paying capacity.

            h. If the Company in any manner grants any rights or options to
subscribe  for or to  purchase  Common  Stock or any  stock or other  securities
convertible  into or exchangeable for Common Stock (such rights or options being
herein called "Rights" and such convertible or exchangeable  stock or securities
being herein called "Convertible Securities"), and the price per share for which
Common Stock is issuable upon the exercise of such Rights or upon  conversion or
exchange  of such  Convertible  Securities  is less than the  Exercise  Price in
effect  immediately  prior to the time of the granting of such Rights,  then the
total  maximum  number of shares of Common Stock  issuable  upon the exercise of
such Rights or upon  conversion or exchange of the total maximum  amount of such
Convertible  Securities issuable upon the exercise of such Rights will be deemed
to be outstanding and to have been issued and sold by the Company for such price
per share.  For purposes of this Section,  the "price per share for which Common
Stock is issuable upon exercise of such Rights or upon conversion or exchange of
such  Convertible  Securities"  will be  determined  by  dividing  (i) the total
amount,  if any,  received or receivable by the Company as consideration for the
granting  of such  Rights,  plus the  minimum  aggregate  amount  of  additional
consideration  payable to the Company upon exercise of all such Rights, plus, in
the case of Rights that relate to Convertible Securities,  the minimum aggregate
amount of  additional  consideration,  if any,  payable to the Company  upon the
issuance or sale of such  Convertible  Securities and the conversion or exchange
thereof,  by (ii) the total  maximum  number of  shares  of  Common  Stock  then
issuable upon the exercise of such Rights or upon the  conversion or exchange of
all Convertible  Securities issuable upon the exercise of such Rights. Except as
otherwise provided in Subsections j. and k. below, no adjustment of the Exercise
Price will be made when  Convertible  Securities  are  actually  issued upon the
exercise  of such  Rights  or when  Common  Stock is  actually  issued  upon the
exercise  of such  Rights or the  conversion  or  exchange  of such  Convertible
Securities.

            i. If the Company in any manner issues or sells any Convertible
Securities, and the price per share for which Common Stock is issuable upon such
conversion  or exchange is less than the  Exercise  Price in effect  immediately
prior to the time of such issuance or sale, then the maximum number of shares of
Common Stock then issuable upon  conversion or exchange of all such  Convertible
Securities  will be deemed to be outstanding and to have been issued and sold by
the Company for such price per share, as determined  below.  For the purposes of
this Section,  the "price per share for which Common Stock is issuable upon such
conversion  or  exchange"  will be  determined  by dividing (i) the total amount
received or receivable by the Company as consideration  for the issuance or sale
of such Convertible Securities,  plus the minimum aggregate amount of additional
consideration,  if any,  payable to the Company upon the  conversion or exchange
thereof,  by (ii) the total  maximum  number of  shares  of  Common  Stock  then
issuable  upon the  conversion or exchange of all such  Convertible  Securities.
Except as otherwise  provided in Subsections  j. and k. below,  no adjustment of
the

CORP\02437\0068\LCFJLS12.21A
970408
                                       -8-

<PAGE>



Exercise  Price  will be made when  Common  Stock is  actually  issued  upon the
conversion or exchange of such Convertible Securities,  and if any such issuance
or sale of such Convertible  Securities is made upon exercise of any Convertible
Securities  for which  adjustments  of the Exercise  Price had been or are to be
made pursuant to other  provisions  of this Section 7, no further  adjustment of
the Exercise Price will be made by reason of such issuance or sale.

            j.  If the purchase price provided for in any Rights, the additional
consideration,   if  any,  payable  upon  the  conversion  or  exchange  of  any
Convertible  Securities,  or the rate at which any  Convertible  Securities  are
convertible  into or  exchangeable  for Common Stock  changes at any time (other
than under or by reason of  provisions  that are  designed  to  protect  against
dilution of the type set forth in this  Section 7 and are no more  favorable  to
the holders of such Rights or Convertible  Securities  than this Section 7 would
have  been  if this  Section  7 were  included  in such  Rights  or  Convertible
Securities),  then the Exercise  Price in effect at the time of such change will
be re-adjusted to the Exercise Price that would have been in effect at such time
had such Rights or Convertible  Securities still  outstanding  provided for such
changed purchase price, additional consideration, or changed conversion rate, as
the case may be,  at the  time  initially  granted,  issued,  or sold;  and such
adjustment of the Exercise  Price will be made whether the result  thereof is to
increase  or reduce  the  Exercise  Price  then in effect  under  this  Warrant,
provided that no such  adjustment  shall  increase the Exercise  Price above the
initial  Exercise  Price hereof and that such  adjustments  shall be made by the
Board of Directors of the Company,  who shall promptly provide notice of the new
Exercise Price to the Holder.

            k. Upon the expiration of any Right, or the termination of any right
to convert or exchange any  Convertible  Security,  without the exercise of such
Right, or the conversion of such Convertible  Security,  the Exercise Price then
in effect  hereunder will be adjusted to the Exercise Price that would have been
in  effect  at the time of such  expiration  or  termination  had such  Right or
Convertible Security never been issued, but such subsequent adjustment shall not
affect the number of shares of Common  Stock  issued  upon any  exercise of this
Warrant prior to the date such adjustment is made.

            l.  If any shares of Common Stock, Rights, or Convertible Securities
are issued or sold or deemed to have been issued or sold for consideration  that
includes cash, then the amount of cash  consideration  actually  received by the
Company will be deemed to be the cash portion  thereof.  If any shares of Common
Stock,  Rights,  or Convertible  Securities are issued or sold or deemed to have
been issued or sold for a consideration part or all of which is other than cash,
then the amount of the  consideration  other than cash  received  by the Company
will be the fair  value of such  consideration  as  determined  by the  Board of
Directors  of  the  Company,   except  where  such  consideration   consists  of
securities,  in which case the amount of  consideration  received by the Company
will be the market  value  thereof as of the date of  receipt.  If any shares of
Common Stock,  Rights,  or Convertible  Securities are issued in connection with
any merger or consolidation  in which the Company is the surviving  corporation,
then the amount of consideration therefor will be deemed to be the fair value of
such portion of the net assets and business of the non-surviving  corporation as
is attributable to such Common Stock, Rights, or Convertible Securities,  as the
case may be.

CORP\02437\0068\LCFJLS12.21A
970408
                                       -9-

<PAGE>




            m. If any Right is issued in connection with the issuance or sale of
other securities of the Company,  together comprising one integrated transaction
in which no specific  consideration  is  allocated  to such Right by the parties
thereto, the Right will be deemed to have been issued without consideration.

            n.   The number of shares of Common Stock deemed outstanding at any
given time shall  include the number of shares of Common Stock  outstanding,  as
adjusted as provided  herein,  but shall not include  shares owned or held by or
for the account of the Company,  and the  disposition  of any shares so owned or
held will be considered an issuance or sale of Common Stock hereunder.

            o.   No adjustment of the Exercise Price shall be made if the amount
of such  adjustment  would be less than one cent per Warrant Share,  but in such
case any adjustment that otherwise would be required to be made shall be carried
forward  and  shall be made at the time and  together  with the next  subsequent
adjustment that, together with any adjustment or adjustments so carried forward,
shall amount to not less than one cent per Warrant Share.

        7.2 In the event of any reorganization or  reclassification of
the  outstanding  shares of Common Stock  (other than a change in par value,  or
from no par  value to par  value,  or from par  value to no par  value,  or as a
result of a subdivision or combination) or in the event of any  consolidation or
merger of the Company with another entity at any time prior to the expiration of
this Warrant,  the Holder shall have the right to exercise  this  Warrant.  Upon
such  exercise,  the Holder  shall  have the right to receive  the same kind and
number of shares of capital stock and other  securities,  cash or other property
as  would  have  been  distributed  to  the  Holder  upon  such  reorganization,
reclassification,  consolidation  or  merger.  The  Holder  shall  pay upon such
exercise the Exercise Price that otherwise  would have been payable  pursuant to
the  terms  of  this  Warrant.  If any  such  reorganization,  reclassification,
consolidation  or merger  results in a cash  distribution  in excess of the then
applicable Exercise Price, the Holder may, at the Holder's option, exercise this
Warrant  without  making  payment of the  Exercise  Price,  and in such case the
Company shall, upon  distribution to the Holder,  consider the Exercise Price to
have been paid in full, and in making settlement to the Holder,  shall deduct an
amount equal to the Exercise Price from the amount payable to the Holder. In the
event of any such  reorganization,  merger  or  consolidation,  the  corporation
formed by such  consolidation  or merger or the  corporation  which  shall  have
acquired the assets of the Company shall execute and deliver a supplement hereto
to the foregoing  effect,  which  supplement  shall also provide for adjustments
which shall be as nearly  equivalent as may be  practicable  to the  adjustments
provided in the Warrant.

        7.3 If the Company shall, at any time before the expiration of
this Warrant, dissolve,  liquidate or wind up its affairs, the Holder shall have
the right to exercise this Warrant. Upon such exercise the Holder shall have the
right to receive,  in lieu of the shares of Common Stock of the Company that the
Holder  otherwise would have been entitled to receive,  the same kind and amount
of assets as would have been issued, distributed or paid to the Holder upon any

CORP\02437\0068\LCFJLS12.21A
970408
                                      -10-

<PAGE>



such  dissolution,  liquidation  or  winding  up  with  respect  to  such  stock
receivable  upon  exercise  of this  Warrant on the date for  determining  those
entitled to receive any such distribution. If any such dissolution,  liquidation
or winding up results in any cash  distribution  in excess of the Exercise Price
provided by this Warrant, the Holder may, at the Holder's option,  exercise this
Warrant  without  making  payment of the Exercise  Price and, in such case,  the
Company shall, upon  distribution to the Holder,  consider the Exercise Price to
have been paid in full and, in making settlement to the Holder,  shall deduct an
amount equal to the Exercise Price from the amount payable to the Holder.

        7.4 Upon each  adjustment  of the Exercise  Price  pursuant to
Section 7 hereof, the Holder shall thereafter (until another such adjustment) be
entitled to purchase,  at the adjusted Exercise Price in effect on the date this
Warrant is exercised,  the number of Warrant  Shares,  calculated to the nearest
number of Warrant  Shares,  determined by (a)  multiplying the number of Warrant
Shares purchasable hereunder immediately prior to the adjustment of the Exercise
Price by the Exercise Price in effect immediately prior to such adjustment,  and
(b) dividing the product so obtained by the adjusted Exercise Price in effect on
the date of such exercise. The provisions of Section 11 shall apply, however, so
that no fractional  share of Common Stock or fractional  Warrant shall be issued
upon exercise of this Warrant.

        7.5  The  Company  may  retain  a firm of  independent  public
accountants of recognized  standing (who may be any such firm regularly employed
by the  Company) to make any  computation  required  under this Section 7, and a
certificate signed by such firm shall be conclusive  evidence of the correctness
of any computation made under this Section 7.

     8. Voting  Agreement.  Upon exercise of the Warrants,  the Holder shall
agree to vote the Warrant Shares in favor of management's  nominees to the Board
of  Directors  for a period of five years or so long as Holder  owns the Warrant
Shares,  whichever is lesser.  The delivery of the Warrant  Shares to the Holder
shall be contingent upon the execution and delivery to the Company of a document
providing for the foregoing in a form reasonably satisfactory to the Company.

     9. Notice to Holder.  So long as this Warrant shall be outstanding  (a)
if the Company shall pay any dividends or make any distribution  upon the Common
Stock  otherwise than in cash or (b) if the Company shall offer generally to the
holders of Common  Stock the right to subscribe to or purchase any shares of any
class of capital  stock or  securities  convertible  into  capital  stock or any
similar  rights  or (c) if there  shall  be any  capital  reorganization  of the
Company in which the Company is not the surviving  entity,  recapitalization  of
the capital stock of the Company, consolidation or merger of the Company with or
into another corporation,  sale, lease or other transfer of all or substantially
all of the  property and assets of the  Company,  or  voluntary  or  involuntary
dissolution,  liquidation or winding up of the Company,  then in such event, the
Company shall cause to be mailed by registered or certified  mail to the Holder,
at least 30 days prior to the  relevant  date  described  below (or such shorter
period as is  reasonably  possible  if 30 days is not  reasonably  possible),  a
notice  containing a description of the proposed  action and stating the date or
expected date on which a record of the Company's stockholders

CORP\02437\0068\LCFJLS12.21A
970408
                                      -11-

<PAGE>



is to be taken for the purpose of any such dividend,  distribution of rights, or
such  reorganization,  recapitalization,  consolidation,  merger, sale, lease or
transfer,  dissolution,  liquidation or winding up is to take place and the date
or expected date, if any is to be fixed, as of which the holders of Common Stock
of record  shall be  entitled  to  exchange  their  shares  of Common  Stock for
securities or other property deliverable upon such event.

     10. Certificate of Adjustment. Whenever the Exercise Price or number or
type of securities issuable upon exercise of this Warrant is adjusted, as herein
provided,  the Company  shall  promptly  deliver to the Holder of this Warrant a
certificate  of an  officer  of the  Company  setting  forth the  nature of such
adjustment and a brief statement of the facts requiring such adjustment.

     11. No Fractional  Shares. No fractional shares of Common Stock will be
issued in connection with any subscription  hereunder. In lieu of any fractional
shares which would  otherwise be issuable,  the Company  shall pay cash equal to
the product of such fraction multiplied by the fair market value of one share of
Common  Stock  on the  date of  exercise,  as  determined  in good  faith by the
Company's Board of Directors.

     12. Restrictions on Exercise.

        12.1  Unless,  prior  to the  exercise  of this  Warrant,  the
Warrant  Shares  have  been  registered  with  the  Commission  pursuant  to the
Securities Act, the notice of exercise shall be accompanied by a  representation
of the Holder to the Company that such shares are being  acquired for investment
and not with a view to the distribution  thereof, and such other representations
and  documentation  as may reasonably be required by the Company,  unless in the
opinion of counsel to the Company such representations or other documentation is
not necessary to comply with such the Securities Act.

        12.2 The Company shall not be obligated to deliver any Warrant
Shares  unless and until the Company has compiled with any  requirements  of the
securities exchange or other  self-regulatory body on which the Company's shares
of Common  Stock may be listed or until  there has been  qualification  under or
compliance with such federal or state laws,  rules or  regulations.  The Company
agrees and undertakes to comply with such laws,  rules or  regulations  promptly
upon  receipt by the Company of the  Election to  Purchase,  and in any event by
such date as compliance is required.  Notwithstanding  anything contained herein
to the  contrary,  where the  actions  described  herein may be taken  after the
issuance of the Warrant  Shares,  the Company  will  promptly  issue the Warrant
Shares and thereafter take such appropriate action.

     13. Restrictions on Transfer.

        13.1  Neither  this  Warrant  nor any  Warrant  Shares  may be
transferred  except as  follows:  (a) to a person who, in the opinion of counsel
satisfactory  to the  Company,  is a person to whom this  Warrant or the Warrant
Shares may legally be transferred without  registration and without the delivery
of a current prospectus under the Securities Act with respect

CORP\02437\0068\LCFJLS12.21A
970408
                                      -12-

<PAGE>



thereto and then only  against  receipt of an agreement of such person to comply
with the  provisions  of this  Section 13 with  respect to any  Transfer of such
securities;  or (b) to any person upon delivery of a prospectus then meeting the
requirements  of the Securities Act relating to such securities and the offering
thereof for such Transfer.

        13.2  Unless,  prior  to the  exercise  of this  Warrant,  the
Warrant  Shares  have  been  registered  with  the  Commission  pursuant  to the
Securities  Act,  upon  exercise of this Warrant and the issuance of the Warrant
Shares, all certificates representing such Warrant Shares shall bear on the face
or reverse thereof substantially the following legend:

                  THE  SHARES  REPRESENTED  BY THIS  CERTIFICATE  HAVE  NOT BEEN
                  REGISTERED  UNDER THE SECURITIES  ACT OF 1933, AS AMENDED,  OR
                  ANY STATE  SECURITIES  LAWS AND MAY NOT BE SOLD,  OFFERED  FOR
                  SALE, PLEDGED, TRANSFERRED,  ASSIGNED OR OTHERWISE DISPOSED OF
                  UNLESS  REGISTERED  PURSUANT TO THE PROVISIONS OF SUCH ACT AND
                  STATE  SECURITIES LAWS OR AN OPINION OF COUNSEL TO THE COMPANY
                  IS OBTAINED  STATING THAT SUCH SALE,  OFFER FOR SALE,  PLEDGE,
                  TRANSFER,  ASSIGNMENT  OR OTHER  DISPOSITION  IS IN COMPLIANCE
                  WITH AN AVAILABLE EXEMPTION FROM SUCH REGISTRATION.

     14. Lost,  Stolen or Destroyed  Warrants.  In the event that the Holder
notifies the Company that this  Warrant has been lost,  stolen or destroyed  and
either (a) provides a letter, in form satisfactory to the Company, to the effect
that it will  indemnify  the Company from any loss  incurred by it in connection
therewith, and/or (b) provides an indemnity bond in such amount as is reasonably
required by the Company,  the Company shall accept such letter and/or  indemnity
bond in lieu of the surrender of this Warrant as required by Section 2 hereof.

     15.  Exchange or Assignment of Warrant.  This Warrant is  exchangeable,
without expense,  at the option of the Holder,  upon  presentation and surrender
hereof to the Company, for other Warrants of different denominations,  entitling
the Holder to purchase in the  aggregate  the same number of shares  purchasable
hereunder.  Subject to the provisions of this Warrant and receipt by the Company
of any required  representations and agreements,  upon surrender of this Warrant
to the  Company  with the  Assignment  annexed  hereto duly  executed  and funds
sufficient  to pay any  transfer  tax,  the Company  shall,  without  additional
charge,  execute and deliver a new Warrant in the name of the assignee  named in
such instrument of assignment and this Warrant shall promptly be canceled.

     16. Notices. Notices and other communications to be given to the Holder
shall be deemed sufficiently given if delivered by hand, or five days after 
mailing by registered or certified mail, postage prepaid, to the Holder at 4~. 
Notices or other communications to the Company shall be deemed to have been 
sufficiently given if delivered by hand or five days after

CORP\02437\0068\LCFJLS12.21A
970408
                                      -13-

<PAGE>



mailing if mailed by  registered  or  certified  mail  postage  prepaid,  to the
Company at 26 Harbor Park Drive, Port Washington,  New York 11050. A party may
change the address to which  notice  shall be given by notice  pursuant to this
Section 16.

     17. Enforcement. Should it become necessary for any party to institute
legal action to enforce the terms and conditions of this Warrant, the successful
party will be awarded reasonable attorneys' fees at all trial and appellate 
levels, expenses and costs.

     18. Entire  Agreement and  Modification.  The Company and the Holder of
this Warrant  hereby  represent and warrant that this Warrant is intended to and
does contain and embody all of the understandings  and agreements,  both written
and oral,  of the  parties  hereto with  respect to the  subject  matter of this
Warrant,  and that there exists no oral agreement or  understanding,  express or
implied,  whereby the absolute,  final and unconditional character and nature of
this  Warrant  shall  be  in  any  way  invalidated,  impaired  or  affected.  A
modification  or waiver of any of the terms,  conditions  or  provisions of this
Warrant  shall be effective  only if made in writing and executed  with the same
formality of this Warrant.

     19. Governing Law. This Warrant shall be governed by and construed in 
accordance with the laws of the State of Delaware, without application of the 
principles of conflicts of laws.

         IN WITNESS  WHEREOF,  the Company has  executed  this Warrant as of the
23rd day of December, 1996.

                                    SANDATA, INC., a Delaware corporation



                                    By:
                                        Bert E. Brodsky, President


CORP\02437\0068\LCFJLS12.21A
970408
                                      -14-

<PAGE>



                              ELECTION TO PURCHASE


TO:      Sandata, Inc.

         The  undersigned   hereby   irrevocably  elects  to  exercise  Warrants
represented    by   this   Common   Stock    Purchase    Warrant   to   purchase
____________________  shares of Common Stock  issuable upon the exercise of such
Warrants and requests  that  certificates  for such shares be issued in the name
of:


           (Please insert social security or other identifying number)


                         (Please print name and address)


Dated:  ____________________, 19__

         NOTICE: The signature on this Election to Purchase must correspond with
the name as written upon the face of the within  Warrant,  in every  particular,
without  alteration,   enlargement,  or  any  change  whatsoever,  and  must  be
guaranteed  by  a  bank,  other  than  a  savings  bank,  having  an  office  or
correspondent in New York, New York, Boca Raton or Miami,  Florida, or by a firm
having membership on a registered  national securities exchange and an office in
New York, New York, or Boca Raton or Miami, Florida.


                               SIGNATURE GUARANTEE


Authorized Signature:

Name of Bank or Firm:

Dated:



CORP\02437\0068\LCFJLS12.21A
970408
                                      -15-

<PAGE>


                                   ASSIGNMENT

         FOR VALUE RECEIVED, __________________________________________, the
undersigned Holder hereby sells, assigns, and transfers all of the rights of the
undersigned  under the  within  Warrant  with  respect  to the  number of Shares
covered thereby set forth below,  unto the Assignee  identified  below, and does
hereby           irrevocably           constitute           and          appoint
________________________________________  to effect  such  transfer of rights on
the books of the Company, with full power of substitution:

Name of Assignee     Address of Assignee    No. of Shares        Exercise Price










Dated:
                                                          (Signature of Holder)



                                                           (Print or type name)


         NOTICE:  The signature on this Assignment must correspond with the name
as written upon the face of the within  Warrant,  in every  particular,  without
alteration,  enlargement,  or any change whatsoever, and must be guaranteed by a
bank, other than a savings bank,  having an office or correspondent in New York,
New York,  Boca Raton or Miami,  Florida,  or by a firm having  membership  on a
registered  national securities exchange and an office in New York, New York, or
Boca Raton or Miami, Florida.


                               SIGNATURE GUARANTEE


Authorized Signature:

Name of Bank or Firm:

Dated:

CORP\02437\0068\LCFJLS12.21A
970408
                                      -16-

<PAGE>

                         CONSENT OF INDEPENDENT AUDITORS




To the Board of Directors and Shareholders
of Sandata, Inc.

     We consent to the reference to our firm under the caption  "Experts" in the
Registration Statement (Form S-3) and related prospectus of Sandata, Inc. and to
the  incorporation by reference therein of our report dated August 16, 1996 with
respect to the consolidated  financial  statements included in its Annual Report
on Form  10-KSB  for the year ended May 31,  1996,  as  amended,  filed with the
Securities and Exchange Commission.



/s/ Marcum & Klieman LLP

Marcum & Kliegman LLP


Woodbury, New York
April 24, 1997


<PAGE>




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission